sampleID	_EVENT	_INTEGRATION	_OS	_OS_IND	_PATIENT	_RFS	_RFS_IND	_TIME_TO_EVENT	_anatomical_origin	_cohort	_primary_disease	additional_pharmaceutical_therapy	additional_radiation_therapy	age_at_initial_pathologic_diagnosis	atypical_mitotic_figures	bcr_followup_barcode	clinical_M	ct_scan_findings	cytoplasm_presence_less_than_equal_25_percent	days_to_birth	days_to_collection	days_to_death	days_to_initial_pathologic_diagnosis	days_to_last_followup	days_to_new_tumor_event_additional_surgery_procedure	days_to_new_tumor_event_after_initial_treatment	diffuse_architecture	distant_metastasis_anatomic_site	excess_adrenal_hormone_diagnosis_method_type	excess_adrenal_hormone_history_type	form_completion_date	gender	histologic_disease_progression_present_indicator	histological_type	history_of_neoadjuvant_treatment	icd_10	icd_o_3_histology	icd_o_3_site	informed_consent_verified	initial_weight	invasion_of_tumor_capsule	is_ffpe	laterality	lost_follow_up	lymph_node_examined_count	metastatic_neoplasm_confirmed_diagnosis_method_name	metastatic_neoplasm_confirmed_diagnosis_method_text	mitoses_count	mitotane_therapy	mitotane_therapy_adjuvant_setting	mitotane_therapy_for_macroscopic_residual_disease	mitotic_rate	molecular_analysis_performed_indicator	necrosis	new_neoplasm_confirmed_diagnosis_method_name	new_neoplasm_event_occurrence_anatomic_site	new_neoplasm_event_type	new_neoplasm_occurrence_anatomic_site_text	new_tumor_event_additional_surgery_procedure	new_tumor_event_after_initial_treatment	nuclear_grade_III_IV	number_of_lymphnodes_positive_by_he	oct_embedded	pathologic_N	pathologic_T	pathologic_stage	pathology_report_file_name	percent_lymphocyte_infiltration_TOP	percent_monocyte_infiltration_TOP	percent_necrosis_TOP	percent_neutrophil_infiltration_TOP	percent_normal_cells_TOP	percent_stromal_cells_TOP	percent_tumor_cells_TOP	percent_tumor_nuclei_TOP	person_neoplasm_cancer_status	post_surgical_procedure_assessment_thyroid_gland_carcinoma_stats	postoperative_rx_tx	primary_lymph_node_presentation_assessment	primary_therapy_outcome_success	prior_dx	radiation_therapy	residual_tumor	ret	sample_type	sample_type_id	sinusoid_invasion	therapeutic_mitotane_levels_achieved	therapeutic_mitotane_lvl_macroscopic_residual	therapeutic_mitotane_lvl_progression	therapeutic_mitotane_lvl_recurrence	tissue_prospective_collection_indicator	tissue_retrospective_collection_indicator	tissue_source_site	tumor_tissue_site	vial_number	vital_status	weiss_score	weiss_venous_invasion	year_of_initial_pathologic_diagnosis	_GENOMIC_ID_TCGA_ACC_GSNP6raw	_GENOMIC_ID_TCGA_ACC_gistic2thd	_GENOMIC_ID_TCGA_ACC_mutation_ucsc_vcf_gene	_GENOMIC_ID_TCGA_ACC_GSNP6noCNV	_GENOMIC_ID_TCGA_ACC_mutation_bcm_gene	_GENOMIC_ID_TCGA_ACC_RPPA	_GENOMIC_ID_TCGA_ACC_mutation_curated_bcm_gene	_GENOMIC_ID_TCGA_ACC_hMethyl450	_GENOMIC_ID_TCGA_ACC_exp_HiSeqV2	_GENOMIC_ID_TCGA_ACC_mutation_curated_broad_gene	_GENOMIC_ID_TCGA_ACC_PDMRNAseqCNV	_GENOMIC_ID_TCGA_ACC_exp_HiSeqV2_PANCAN	_GENOMIC_ID_TCGA_ACC_exp_HiSeqV2_exon	_GENOMIC_ID_TCGA_ACC_PDMRNAseq	_GENOMIC_ID_TCGA_ACC_exp_HiSeqV2_percentile	_GENOMIC_ID_TCGA_ACC_gistic2	_GENOMIC_ID_TCGA_ACC_miRNA_HiSeq	_GENOMIC_ID_TCGA_ACC_mutation_ucsc_maf_gene
TCGA-OR-A5J1-01	1	TCGA-OR-A5J1-01	1355	1	TCGA-OR-A5J1	754	1	1355	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer	NO	NO	58	Atypical Mitotic Figures Absent	TCGA-OR-A5J1-F60566	M0		Cytoplasm presence <= 25% Present	-21496	4691	1355	0			754	Diffuse Architecture Present			Mineralocorticoids	2014-6-11	MALE	YES	Adrenocortical carcinoma- Usual Type	No	C74.0	8370/1	C74.0	YES	40	Invasion of Tumor Capsule Absent	NO	Left	NO				5	NO	NO		Mitotic Rate > 5/50 HPF Absent	NO	Necrosis Present	Imaging	Peritoneal Surfaces	Distant Metastasis		NO	YES	Nuclear Grade III or IV Absent		true	N0	T2	Stage II	TCGA-OR-A5J1.8866FD87-4F6F-4D7E-B99A-7DD427ED3BB3.pdf	2	0	0	0	0	0	100	80	WITH TUMOR	Persistent distant metastases	NO		Complete Remission/Response	No	NO	R0		Primary Tumor	01	Sinusoid Invasion Absent					NO	YES	OR	Adrenal	A	DECEASED	3	Venous Invasion Absent	2000	1387b6c7-48fe-4961-86a7-0bdcbd3fef92	TCGA-OR-A5J1-01A-11D-A29H-01	TCGA-OR-A5J1-01A-11D-A29I-10	1387b6c7-48fe-4961-86a7-0bdcbd3fef92	TCGA-OR-A5J1-01A-11D-A29I-10		TCGA-OR-A5J1-01A-11D-A29I-10	TCGA-OR-A5J1-01A-11D-A29J-05	37e88158-0743-45b8-87cf-1d7fe878527f	TCGA-OR-A5J1-01A-11D-A29I-10	TCGA-OR-A5J1-01	37e88158-0743-45b8-87cf-1d7fe878527f	37e88158-0743-45b8-87cf-1d7fe878527f	TCGA-OR-A5J1-01	37e88158-0743-45b8-87cf-1d7fe878527f	TCGA-OR-A5J1-01A-11D-A29H-01	TCGA-OR-A5J1-01A-11R-A29W-13	TCGA-OR-A5J1-01A-11D-A29I-10
TCGA-OR-A5J2-01	1	TCGA-OR-A5J2-01	1677	1	TCGA-OR-A5J2			1677	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			44	Atypical Mitotic Figures Present		M1	Lung Involvement	Cytoplasm presence <= 25% Present	-16090	3124	1677	0				Diffuse Architecture Present		Both Clinical and Biochemical Assessments	Androgen	2013-12-3	FEMALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	350	Invasion of Tumor Capsule Present	NO	Left		1	Imaging Suspected		0	YES		YES	Mitotic Rate > 5/50 HPF Absent	NO	Necrosis Present						YES	Nuclear Grade III or IV Present	0	true	N0	T3	Stage IV	TCGA-OR-A5J2.345C34EE-F031-41A4-B955-BA054F2A3CE1.pdf	0	0	5	0	0	5	90	95	WITH TUMOR	Persistent distant metastases	YES	YES	Progressive Disease	No	NO	R2		Primary Tumor	01	Sinusoid Invasion Present					NO	YES	OR	Adrenal	A	DECEASED	8	Venous Invasion Present	2004	6f0290b0-4cb4-4f72-853e-9ac363bd2c3b	TCGA-OR-A5J2-01A-11D-A29H-01	TCGA-OR-A5J2-01A-11D-A29I-10	6f0290b0-4cb4-4f72-853e-9ac363bd2c3b	TCGA-OR-A5J2-01A-11D-A29I-10	F9762BBB-BCA0-4B54-A2C8-6F81A91DE22F	TCGA-OR-A5J2-01A-11D-A29I-10	TCGA-OR-A5J2-01A-11D-A29J-05	421bbd6b-fb2a-4a6d-a298-057c1b65f041	TCGA-OR-A5J2-01A-11D-A29I-10	TCGA-OR-A5J2-01	421bbd6b-fb2a-4a6d-a298-057c1b65f041	421bbd6b-fb2a-4a6d-a298-057c1b65f041	TCGA-OR-A5J2-01	421bbd6b-fb2a-4a6d-a298-057c1b65f041	TCGA-OR-A5J2-01A-11D-A29H-01	TCGA-OR-A5J2-01A-11R-A29W-13	TCGA-OR-A5J2-01A-11D-A29I-10
TCGA-OR-A5J3-01	0	TCGA-OR-A5J3-01	2091	0	TCGA-OR-A5J3	1149	1	2091	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer	YES	NO	23	Atypical Mitotic Figures Absent	TCGA-OR-A5J3-F59590	M0	Vena Cava Involvement/thrombus	Cytoplasm presence <= 25% Present	-8624	1584		0	2091	1583	1149	Diffuse Architecture Present		Both Clinical and Biochemical Assessments	Androgen|Cortisol	2014-5-15	FEMALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	310	Invasion of Tumor Capsule Absent	NO	Left	NO	4			6	YES	YES		Mitotic Rate > 5/50 HPF Present	YES	Necrosis Present	Imaging	Lung	Distant Metastasis		YES	YES	Nuclear Grade III or IV Present	0	true	N0	T3	Stage III	TCGA-OR-A5J3.83F53610-4F40-425B-9B69-BBB94234224F.pdf	2	0	0	0	0	0	100	80	WITH TUMOR	No imaging evidence of disease	NO	YES	Complete Remission/Response	No	NO	R0		Primary Tumor	01	Sinusoid Invasion Absent	YES			YES	NO	YES	OR	Adrenal	A	LIVING	6	Venous Invasion Present	2008	77b628c4-5573-4c4d-b52e-10f93d35b05b	TCGA-OR-A5J3-01A-11D-A29H-01	TCGA-OR-A5J3-01A-11D-A29I-10	77b628c4-5573-4c4d-b52e-10f93d35b05b	TCGA-OR-A5J3-01A-11D-A29I-10	21AB5BC5-D822-4C70-BAD0-1E390A55456E	TCGA-OR-A5J3-01A-11D-A29I-10	TCGA-OR-A5J3-01A-11D-A29J-05	83b02107-0c7c-450d-84aa-9ed4e1d755c5	TCGA-OR-A5J3-01A-11D-A29I-10	TCGA-OR-A5J3-01	83b02107-0c7c-450d-84aa-9ed4e1d755c5	83b02107-0c7c-450d-84aa-9ed4e1d755c5	TCGA-OR-A5J3-01	83b02107-0c7c-450d-84aa-9ed4e1d755c5	TCGA-OR-A5J3-01A-11D-A29H-01	TCGA-OR-A5J3-01A-11R-A29W-13	TCGA-OR-A5J3-01A-11D-A29I-10
TCGA-OR-A5J4-01	1	TCGA-OR-A5J4-01	423	1	TCGA-OR-A5J4			423	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			23	Atypical Mitotic Figures Absent		M1	Lung Involvement	Cytoplasm presence <= 25% Absent	-8451	4642	423	0				Diffuse Architecture Present		Both Clinical and Biochemical Assessments	Androgen|Cortisol	2013-12-2	FEMALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	80	Invasion of Tumor Capsule Present	NO	Right		2	Imaging Suspected		77	YES		YES	Mitotic Rate > 5/50 HPF Present	NO	Necrosis Present						YES	Nuclear Grade III or IV Present	2	true	N1	T3	Stage IV	TCGA-OR-A5J4.39E300DC-C01F-46BC-AE4C-D834458F1FF7.pdf	2	0	18	0	0	0	82	80	WITH TUMOR	Persistent distant metastases	YES	YES	Progressive Disease	No	NO	R2		Primary Tumor	01	Sinusoid Invasion Absent					NO	YES	OR	Adrenal	A	DECEASED	6	Venous Invasion Present	2000	8aa24da8-071b-4cd2-a1d8-480ee049c863	TCGA-OR-A5J4-01A-11D-A29H-01	TCGA-OR-A5J4-01A-11D-A29I-10	8aa24da8-071b-4cd2-a1d8-480ee049c863	TCGA-OR-A5J4-01A-11D-A29I-10		TCGA-OR-A5J4-01A-11D-A29I-10	TCGA-OR-A5J4-01A-11D-A29J-05		TCGA-OR-A5J4-01A-11D-A29I-10						TCGA-OR-A5J4-01A-11D-A29H-01	TCGA-OR-A5J4-01A-11R-A29W-13	TCGA-OR-A5J4-01A-11D-A29I-10
TCGA-OR-A5J5-01	1	TCGA-OR-A5J5-01	365	1	TCGA-OR-A5J5			365	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			30	Atypical Mitotic Figures Present		M0	Retroperitoneal Lymph Node Involvement	Cytoplasm presence <= 25% Absent	-11171	4537	365	0				Diffuse Architecture Absent			None	2013-12-3	MALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	40	Invasion of Tumor Capsule Present	NO	Right					3	YES		YES	Mitotic Rate > 5/50 HPF Absent	NO	Necrosis Present						YES	Nuclear Grade III or IV Present		true	N0	T4	Stage III	TCGA-OR-A5J5.BB63299C-B7F7-4F08-998D-C30E56CD6065.pdf	2	0	0	0	0	0	100	80	WITH TUMOR	Persistent locoregional disease	YES	NO	Progressive Disease	No	NO	R2		Primary Tumor	01	Sinusoid Invasion Present					NO	YES	OR	Adrenal	A	DECEASED	6	Venous Invasion Present	2000	9e704a46-2d0c-48c9-a6fa-1566d67a75e8	TCGA-OR-A5J5-01A-11D-A29H-01	TCGA-OR-A5J5-01A-11D-A29I-10	9e704a46-2d0c-48c9-a6fa-1566d67a75e8	TCGA-OR-A5J5-01A-11D-A29I-10		TCGA-OR-A5J5-01A-11D-A29I-10	TCGA-OR-A5J5-01A-11D-A29J-05	f72bfbe6-411d-412e-aaab-1a2414e544ec	TCGA-OR-A5J5-01A-11D-A29I-10	TCGA-OR-A5J5-01	f72bfbe6-411d-412e-aaab-1a2414e544ec	f72bfbe6-411d-412e-aaab-1a2414e544ec	TCGA-OR-A5J5-01	f72bfbe6-411d-412e-aaab-1a2414e544ec	TCGA-OR-A5J5-01A-11D-A29H-01	TCGA-OR-A5J5-01A-11R-A29W-13	TCGA-OR-A5J5-01A-11D-A29I-10
TCGA-OR-A5J6-01	0	TCGA-OR-A5J6-01	2703	0	TCGA-OR-A5J6	2703	0	2703	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			29	Atypical Mitotic Figures Absent	TCGA-OR-A5J6-F59329	M0	Normal	Cytoplasm presence <= 25% Present	-10839	2220		0	2703			Diffuse Architecture Present		Both Clinical and Biochemical Assessments	Androgen|Cortisol	2014-5-8	FEMALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	340	Invasion of Tumor Capsule Absent	NO	Right	NO					NO	NO		Mitotic Rate > 5/50 HPF Present	YES	Necrosis Absent						NO	Nuclear Grade III or IV Absent		true	N0	T2	Stage II	TCGA-OR-A5J6.F664D25E-9050-460D-AEAE-AA4BFA515453.pdf	0	0	0	0	0	0	100	88	TUMOR FREE	No imaging evidence of disease	NO	NO	Complete Remission/Response	No	NO	R0		Primary Tumor	01	Sinusoid Invasion Absent					NO	YES	OR	Adrenal	A	LIVING	3	Venous Invasion Absent	2006	76f1fa71-2fe0-4a5a-ac6a-22387c14bc9f	TCGA-OR-A5J6-01A-31D-A29H-01	TCGA-OR-A5J6-01A-31D-A29I-10	76f1fa71-2fe0-4a5a-ac6a-22387c14bc9f	TCGA-OR-A5J6-01A-31D-A29I-10	BBE6AF7B-BCDD-4179-94E2-2978AF7A03A4	TCGA-OR-A5J6-01A-31D-A29I-10	TCGA-OR-A5J6-01A-31D-A29J-05	bb6e0e73-ff48-4627-bce6-f672c06b7de4	TCGA-OR-A5J6-01A-31D-A29I-10	TCGA-OR-A5J6-01	bb6e0e73-ff48-4627-bce6-f672c06b7de4	bb6e0e73-ff48-4627-bce6-f672c06b7de4	TCGA-OR-A5J6-01	bb6e0e73-ff48-4627-bce6-f672c06b7de4	TCGA-OR-A5J6-01A-31D-A29H-01	TCGA-OR-A5J6-01A-31R-A29W-13	TCGA-OR-A5J6-01A-31D-A29I-10
TCGA-OR-A5J7-01	1	TCGA-OR-A5J7-01	490	1	TCGA-OR-A5J7			490	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			30	Atypical Mitotic Figures Present		M0	Normal	Cytoplasm presence <= 25% Present	-11279	1388	490	0				Diffuse Architecture Absent		Both Clinical and Biochemical Assessments	Androgen|Cortisol	2013-12-2	FEMALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	120	Invasion of Tumor Capsule Present	NO	Right		1			3	YES	YES		Mitotic Rate > 5/50 HPF Absent	YES	Necrosis Present						YES	Nuclear Grade III or IV Present	0	true	N0	T3	Stage III	TCGA-OR-A5J7.F9C1971C-5BE2-4722-9A6C-CF4A4AD04352.pdf	2	0	0	0	0	0	100	80	WITH TUMOR	No imaging evidence of disease	YES	YES	Progressive Disease	No	NO	R1		Primary Tumor	01	Sinusoid Invasion Absent	NO				NO	YES	OR	Adrenal	A	DECEASED	6	Venous Invasion Present	2009	3550e483-fe1a-4a5f-a0ca-0560c7a43813	TCGA-OR-A5J7-01A-11D-A29H-01	TCGA-OR-A5J7-01A-11D-A29I-10	3550e483-fe1a-4a5f-a0ca-0560c7a43813	TCGA-OR-A5J7-01A-11D-A29I-10	C89548B7-83CE-40C3-A25C-DE98CEE4415D	TCGA-OR-A5J7-01A-11D-A29I-10	TCGA-OR-A5J7-01A-11D-A29J-05	59eb3b91-d706-45de-9bbe-92b32629c58c	TCGA-OR-A5J7-01A-11D-A29I-10	TCGA-OR-A5J7-01	59eb3b91-d706-45de-9bbe-92b32629c58c	59eb3b91-d706-45de-9bbe-92b32629c58c	TCGA-OR-A5J7-01	59eb3b91-d706-45de-9bbe-92b32629c58c	TCGA-OR-A5J7-01A-11D-A29H-01	TCGA-OR-A5J7-01A-11R-A29W-13	TCGA-OR-A5J7-01A-11D-A29I-10
TCGA-OR-A5J8-01	1	TCGA-OR-A5J8-01	579	1	TCGA-OR-A5J8			579	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			66	Atypical Mitotic Figures Present		M0	Normal	Cytoplasm presence <= 25% Present	-24266	396	579	0				Diffuse Architecture Present		Biochemical Assessment	Cortisol	2013-12-3	MALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	160	Invasion of Tumor Capsule Present	NO	Left		1			15	YES	YES		Mitotic Rate > 5/50 HPF Present	YES	Necrosis Present						YES	Nuclear Grade III or IV Present	0	true	N0	T3	Stage III	TCGA-OR-A5J8.EA68CD7A-9308-40CD-BB52-CEB36334A146.pdf	4	0	0	0	0	0	100	80	WITH TUMOR	No imaging evidence of disease	YES	YES	Complete Remission/Response	No	YES	R0		Primary Tumor	01	Sinusoid Invasion Absent	NO			NO	NO	YES	OR	Adrenal	A	DECEASED	8	Venous Invasion Present	2011	f857dc5c-69e3-4980-89df-44a20c0098a7	TCGA-OR-A5J8-01A-11D-A29H-01	TCGA-OR-A5J8-01A-11D-A29I-10	f857dc5c-69e3-4980-89df-44a20c0098a7	TCGA-OR-A5J8-01A-11D-A29I-10	8D7AD90D-2927-4106-8DB3-C1F9BA8A6A15	TCGA-OR-A5J8-01A-11D-A29I-10	TCGA-OR-A5J8-01A-11D-A29J-05	73fee5d0-d326-484c-95c6-c40c987c6917	TCGA-OR-A5J8-01A-11D-A29I-10	TCGA-OR-A5J8-01	73fee5d0-d326-484c-95c6-c40c987c6917	73fee5d0-d326-484c-95c6-c40c987c6917	TCGA-OR-A5J8-01	73fee5d0-d326-484c-95c6-c40c987c6917	TCGA-OR-A5J8-01A-11D-A29H-01	TCGA-OR-A5J8-01A-11R-A29W-13	TCGA-OR-A5J8-01A-11D-A29I-10
TCGA-OR-A5J9-01	0	TCGA-OR-A5J9-01	1352	0	TCGA-OR-A5J9	414	1	1352	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer	NO	NO	22	Atypical Mitotic Figures Absent	TCGA-OR-A5J9-F59596	M0	Normal	Cytoplasm presence <= 25% Present	-8175	849		0	1352		414	Diffuse Architecture Present			None	2014-5-15	FEMALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	190	Invasion of Tumor Capsule Absent	NO	Right	NO				6	YES	YES		Mitotic Rate > 5/50 HPF Present	NO	Necrosis Present	Imaging	Lung	Distant Metastasis		NO	YES	Nuclear Grade III or IV Present		true	N0	T2	Stage II	TCGA-OR-A5J9.4C775CF4-39D7-4246-87A4-4659783A1C18.pdf	2	0	0	0	0	0	100	80	WITH TUMOR	No imaging evidence of disease	YES	NO	Complete Remission/Response	No	NO	R0		Primary Tumor	01	Sinusoid Invasion Present					NO	YES	OR	Adrenal	A	LIVING	6	Venous Invasion Absent	2010	726707fb-2431-4598-a72d-57bb4467eb0c	TCGA-OR-A5J9-01A-11D-A29H-01	TCGA-OR-A5J9-01A-11D-A29I-10	726707fb-2431-4598-a72d-57bb4467eb0c	TCGA-OR-A5J9-01A-11D-A29I-10	E058CA44-9D1C-40F2-98D1-BC8A31CC4713	TCGA-OR-A5J9-01A-11D-A29I-10	TCGA-OR-A5J9-01A-11D-A29J-05	a818d2cc-4d45-40df-bfcb-9fa08ebf8490	TCGA-OR-A5J9-01A-11D-A29I-10	TCGA-OR-A5J9-01	a818d2cc-4d45-40df-bfcb-9fa08ebf8490	a818d2cc-4d45-40df-bfcb-9fa08ebf8490	TCGA-OR-A5J9-01	a818d2cc-4d45-40df-bfcb-9fa08ebf8490	TCGA-OR-A5J9-01A-11D-A29H-01	TCGA-OR-A5J9-01A-11R-A29W-13	TCGA-OR-A5J9-01A-11D-A29I-10
TCGA-OR-A5JA-01	1	TCGA-OR-A5JA-01	922	1	TCGA-OR-A5JA	922	0	922	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			53	Atypical Mitotic Figures Present		M1	Lung Involvement	Cytoplasm presence <= 25% Present	-19436	2931	922	0				Diffuse Architecture Present	Retroperitoneum	Both Clinical and Biochemical Assessments	Androgen	2013-9-17	FEMALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	180	Invasion of Tumor Capsule Present	NO	Right			Imaging Suspected		90	NO			Mitotic Rate > 5/50 HPF Present	NO	Necrosis Present						NO	Nuclear Grade III or IV Present		true	N0	T4	Stage IV	TCGA-OR-A5JA.6A505565-429B-4D8A-A591-AAB54CF43B66.pdf	0	0	9	0	0	1	90	90	WITH TUMOR	Persistent distant metastases	YES	NO		No	NO	R1		Primary Tumor	01	Sinusoid Invasion Present					NO	YES	OR	Adrenal	A	DECEASED	9	Venous Invasion Present	2004	586958fe-f0d2-466d-be89-af58aea6dc2c	TCGA-OR-A5JA-01A-11D-A29H-01	TCGA-OR-A5JA-01A-11D-A29I-10	586958fe-f0d2-466d-be89-af58aea6dc2c	TCGA-OR-A5JA-01A-11D-A29I-10	969F9640-F208-4C28-91AE-AD429932EC1F	TCGA-OR-A5JA-01A-11D-A29I-10	TCGA-OR-A5JA-01A-11D-A29J-05	d979c964-68e1-4ea4-a473-69b69cba8e5c	TCGA-OR-A5JA-01A-11D-A29I-10	TCGA-OR-A5JA-01	d979c964-68e1-4ea4-a473-69b69cba8e5c	d979c964-68e1-4ea4-a473-69b69cba8e5c	TCGA-OR-A5JA-01	d979c964-68e1-4ea4-a473-69b69cba8e5c	TCGA-OR-A5JA-01A-11D-A29H-01	TCGA-OR-A5JA-01A-11R-A29W-13	TCGA-OR-A5JA-01A-11D-A29I-10
TCGA-OR-A5JB-01	1	TCGA-OR-A5JB-01	551	1	TCGA-OR-A5JB			551	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			52	Atypical Mitotic Figures Present		M1		Cytoplasm presence <= 25% Present	-19172	4678	551	0				Diffuse Architecture Present	brain		None	2013-9-17	MALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	20	Invasion of Tumor Capsule Present	NO	Right			Other, specify	excision of brain met	15				Mitotic Rate > 5/50 HPF Present	NO	Necrosis Present							Nuclear Grade III or IV Present		true	N0	T4	Stage IV	TCGA-OR-A5JB.81022A25-6D64-419D-9B97-22348E17ECEA.pdf	0	0	0	0	0	1	99	99		Persistent distant metastases				No		R1		Primary Tumor	01	Sinusoid Invasion Absent					NO	YES	OR	Adrenal	A	DECEASED	7	Venous Invasion Absent	2000	7428c2c2-e2da-440f-a761-0bc91f45e628	TCGA-OR-A5JB-01A-11D-A29H-01	TCGA-OR-A5JB-01A-11D-A29I-10	7428c2c2-e2da-440f-a761-0bc91f45e628	TCGA-OR-A5JB-01A-11D-A29I-10		TCGA-OR-A5JB-01A-11D-A29I-10	TCGA-OR-A5JB-01A-11D-A29J-05	26861b93-29de-42df-80d6-23260d450391	TCGA-OR-A5JB-01A-11D-A29I-10	TCGA-OR-A5JB-01	26861b93-29de-42df-80d6-23260d450391	26861b93-29de-42df-80d6-23260d450391	TCGA-OR-A5JB-01	26861b93-29de-42df-80d6-23260d450391	TCGA-OR-A5JB-01A-11D-A29H-01	TCGA-OR-A5JB-01A-11R-A29W-13	TCGA-OR-A5JB-01A-11D-A29I-10
TCGA-OR-A5JC-01	1	TCGA-OR-A5JC-01	1750	1	TCGA-OR-A5JC			1750	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			37	Atypical Mitotic Figures Present				Cytoplasm presence <= 25% Present	-13862		1750	0				Diffuse Architecture Present		Biochemical Assessment	Estrogen	2013-9-17	MALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES		Invasion of Tumor Capsule Absent		Left					24				Mitotic Rate > 5/50 HPF Present	NO	Necrosis Present							Nuclear Grade III or IV Present																		NO		No				Primary Tumor	01	Sinusoid Invasion Present					NO	YES	OR	Adrenal		DECEASED	8	Venous Invasion Present	2001	a8bbc616-f4a4-4133-9bc2-35a82c99829d	TCGA-OR-A5JC-01A-11D-A29H-01	TCGA-OR-A5JC-01A-11D-A29I-10	a8bbc616-f4a4-4133-9bc2-35a82c99829d	TCGA-OR-A5JC-01A-11D-A29I-10		TCGA-OR-A5JC-01A-11D-A29I-10	TCGA-OR-A5JC-01A-11D-A29J-05	c51255ac-840d-44c2-87ae-ed91cc635e85	TCGA-OR-A5JC-01A-11D-A29I-10	TCGA-OR-A5JC-01	c51255ac-840d-44c2-87ae-ed91cc635e85	c51255ac-840d-44c2-87ae-ed91cc635e85	TCGA-OR-A5JC-01	c51255ac-840d-44c2-87ae-ed91cc635e85	TCGA-OR-A5JC-01A-11D-A29H-01	TCGA-OR-A5JC-01A-11R-A29W-13	TCGA-OR-A5JC-01A-11D-A29I-10
TCGA-OR-A5JD-01	0	TCGA-OR-A5JD-01	2779	0	TCGA-OR-A5JD	2779	0	2779	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			57	Atypical Mitotic Figures Absent	TCGA-OR-A5JD-F60572	M0		Cytoplasm presence <= 25% Present	-20989	2571		0	2779			Diffuse Architecture Present			None	2014-6-11	FEMALE		Adrenocortical Carcinoma- Oncocytic Type	No	C74.0	8370/3	C74.0	YES	40	Invasion of Tumor Capsule Absent	NO	Left	NO				4		NO		Mitotic Rate > 5/50 HPF Absent	NO	Necrosis Absent						NO	Nuclear Grade III or IV Present		true	N0	T2	Stage II	TCGA-OR-A5JD.AA05D1FB-38B5-4D96-B9EE-07523C95C481.pdf	5	0	0	0	0	10	90	90	TUMOR FREE	No imaging evidence of disease	NO		Complete Remission/Response	No	NO	R0		Primary Tumor	01	Sinusoid Invasion Absent					NO	YES	OR	Adrenal	A	LIVING	3	Venous Invasion Absent	2005	6bc4a981-de91-46d2-916c-15bd70f6670f	TCGA-OR-A5JD-01A-11D-A29H-01	TCGA-OR-A5JD-01A-11D-A29I-10	6bc4a981-de91-46d2-916c-15bd70f6670f	TCGA-OR-A5JD-01A-11D-A29I-10		TCGA-OR-A5JD-01A-11D-A29I-10	TCGA-OR-A5JD-01A-11D-A29J-05	8067d29d-a249-42b9-bd9e-de47513a4230	TCGA-OR-A5JD-01A-11D-A29I-10	TCGA-OR-A5JD-01	8067d29d-a249-42b9-bd9e-de47513a4230	8067d29d-a249-42b9-bd9e-de47513a4230	TCGA-OR-A5JD-01	8067d29d-a249-42b9-bd9e-de47513a4230	TCGA-OR-A5JD-01A-11D-A29H-01	TCGA-OR-A5JD-01A-11R-A29W-13	TCGA-OR-A5JD-01A-11D-A29I-10
TCGA-OR-A5JE-01	1	TCGA-OR-A5JE-01	2105	1	TCGA-OR-A5JE			2105	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			17	Atypical Mitotic Figures Present		M0		Cytoplasm presence <= 25% Present	-6455	2703	2105	0				Diffuse Architecture Present		Biochemical Assessment	Cortisol	2013-9-17	FEMALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	50	Invasion of Tumor Capsule Present	NO	Left					60	YES	YES		Mitotic Rate > 5/50 HPF Present	NO	Necrosis Present						YES	Nuclear Grade III or IV Present		true	N0	T1	Stage I	TCGA-OR-A5JE.80EDB29A-262A-486D-B31A-EA015FA8A362.pdf	0	0	0	0	0	1	99	99	WITH TUMOR		YES			No	NO	R0		Primary Tumor	01	Sinusoid Invasion Present					NO	YES	OR	Adrenal	A	DECEASED	8	Venous Invasion Absent	2005	be71b867-4ae0-4513-bcd0-914eaf87ae55	TCGA-OR-A5JE-01A-11D-A29H-01	TCGA-OR-A5JE-01A-11D-A29I-10	be71b867-4ae0-4513-bcd0-914eaf87ae55	TCGA-OR-A5JE-01A-11D-A29I-10		TCGA-OR-A5JE-01A-11D-A29I-10	TCGA-OR-A5JE-01A-11D-A29J-05	223e2af0-95a2-49f2-84a2-13379cf72ea9	TCGA-OR-A5JE-01A-11D-A29I-10	TCGA-OR-A5JE-01	223e2af0-95a2-49f2-84a2-13379cf72ea9	223e2af0-95a2-49f2-84a2-13379cf72ea9	TCGA-OR-A5JE-01	223e2af0-95a2-49f2-84a2-13379cf72ea9	TCGA-OR-A5JE-01A-11D-A29H-01	TCGA-OR-A5JE-01A-11R-A29W-13	TCGA-OR-A5JE-01A-11D-A29I-10
TCGA-OR-A5JF-01	0	TCGA-OR-A5JF-01	2015	0	TCGA-OR-A5JF	2015	0	2015	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			69	Atypical Mitotic Figures Present	TCGA-OR-A5JF-F60581	M0		Cytoplasm presence <= 25% Present	-25502			0	2015			Diffuse Architecture Absent		Biochemical Assessment	Cortisol	2014-6-11	FEMALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES		Invasion of Tumor Capsule Present		Left	NO				4	YES	YES		Mitotic Rate > 5/50 HPF Absent	NO	Necrosis Absent						NO	Nuclear Grade III or IV Present			N0	T2	Stage II										TUMOR FREE	No imaging evidence of disease	YES		Complete Remission/Response	No	YES	R0		Primary Tumor	01	Sinusoid Invasion Absent	YES				NO	YES	OR	Adrenal		LIVING	4	Venous Invasion Absent	2007	c991274f-9425-4de0-b5ae-4589b40db4c5	TCGA-OR-A5JF-01A-11D-A29H-01	TCGA-OR-A5JF-01A-11D-A29I-10	c991274f-9425-4de0-b5ae-4589b40db4c5	TCGA-OR-A5JF-01A-11D-A29I-10		TCGA-OR-A5JF-01A-11D-A29I-10	TCGA-OR-A5JF-01A-11D-A29J-05	ba350477-3c49-4258-8409-f39447687497	TCGA-OR-A5JF-01A-11D-A29I-10	TCGA-OR-A5JF-01	ba350477-3c49-4258-8409-f39447687497	ba350477-3c49-4258-8409-f39447687497	TCGA-OR-A5JF-01	ba350477-3c49-4258-8409-f39447687497	TCGA-OR-A5JF-01A-11D-A29H-01	TCGA-OR-A5JF-01A-11R-A29W-13	TCGA-OR-A5JF-01A-11D-A29I-10
TCGA-OR-A5JG-01	1	TCGA-OR-A5JG-01	541	1	TCGA-OR-A5JG			541	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			61	Atypical Mitotic Figures Present		M1	Retroperitoneal Lymph Node Involvement	Cytoplasm presence <= 25% Present	-22390	1771	541	0				Diffuse Architecture Present	left cervical lymph node	Both Clinical and Biochemical Assessments	Cortisol	2013-10-3	MALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	60	Invasion of Tumor Capsule Present	NO	Left		8			100	YES			Mitotic Rate > 5/50 HPF Present	NO	Necrosis Present							Nuclear Grade III or IV Present	6	true	N1	T4	Stage IV	TCGA-OR-A5JG.15F6D8D6-878A-410F-8289-D3CEAB7E5D21.pdf	0	0	0	0	0	1	99	99	WITH TUMOR	Persistent distant metastases	YES	YES		No		R1		Primary Tumor	01	Sinusoid Invasion Present					NO	YES	OR	Adrenal	A	DECEASED	9	Venous Invasion Present	2008	73e72d55-f8ea-4f06-b439-62a6d5a81164	TCGA-OR-A5JG-01A-11D-A29H-01	TCGA-OR-A5JG-01A-11D-A29I-10	73e72d55-f8ea-4f06-b439-62a6d5a81164	TCGA-OR-A5JG-01A-11D-A29I-10		TCGA-OR-A5JG-01A-11D-A29I-10	TCGA-OR-A5JG-01A-11D-A29J-05	60c8c1da-fea6-41f7-ba5b-33afba1ef301	TCGA-OR-A5JG-01A-11D-A29I-10	TCGA-OR-A5JG-01	60c8c1da-fea6-41f7-ba5b-33afba1ef301	60c8c1da-fea6-41f7-ba5b-33afba1ef301	TCGA-OR-A5JG-01	60c8c1da-fea6-41f7-ba5b-33afba1ef301	TCGA-OR-A5JG-01A-11D-A29H-01	TCGA-OR-A5JG-01A-11R-A29W-13	TCGA-OR-A5JG-01A-11D-A29I-10
TCGA-OR-A5JH-01	0	TCGA-OR-A5JH-01	2110	0	TCGA-OR-A5JH	2110	0	2110	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			32	Atypical Mitotic Figures Absent	TCGA-OR-A5JH-F60573	M0		Cytoplasm presence <= 25% Present	-11994	1811		0	2110			Diffuse Architecture Present			None	2014-6-11	FEMALE		Adrenocortical Carcinoma- Oncocytic Type	No	C74.0	8370/3	C74.0	YES	20	Invasion of Tumor Capsule Absent	NO	Left	NO				1		NO		Mitotic Rate > 5/50 HPF Absent	NO	Necrosis Present						NO	Nuclear Grade III or IV Present		true	N0	T2	Stage II	TCGA-OR-A5JH.CF498A30-11FC-4F20-A424-E3A1216D54B2.pdf	5	5	0	0	0	5	95	90	TUMOR FREE	No imaging evidence of disease	NO		Complete Remission/Response	No	NO	R0		Primary Tumor	01	Sinusoid Invasion Absent					NO	YES	OR	Adrenal	A	LIVING	4	Venous Invasion Absent	2008	911a42fc-5f01-469f-9375-76c1cd304a30	TCGA-OR-A5JH-01A-11D-A309-01	TCGA-OR-A5JH-01A-11D-A30A-10	911a42fc-5f01-469f-9375-76c1cd304a30	TCGA-OR-A5JH-01A-11D-A30A-10		TCGA-OR-A5JH-01A-11D-A30A-10			TCGA-OR-A5JH-01A-11D-A30A-10						TCGA-OR-A5JH-01A-11D-A309-01		TCGA-OR-A5JH-01A-11D-A30A-10
TCGA-OR-A5JI-01	0	TCGA-OR-A5JI-01	1424	0	TCGA-OR-A5JI	1424	0	1424	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			22	Atypical Mitotic Figures Absent	TCGA-OR-A5JI-F60574	M0	Normal	Cytoplasm presence <= 25% Present	-8177	1499		0	1424			Diffuse Architecture Present			None	2014-6-11	MALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	20	Invasion of Tumor Capsule Absent	NO	Right	NO				1	NO	NO		Mitotic Rate > 5/50 HPF Absent	NO	Necrosis Absent						NO	Nuclear Grade III or IV Present		true	N0	T1	Stage I	TCGA-OR-A5JI.F18AFE4B-5333-418A-A6D0-E347ACA3C06B.pdf	5	0	0	0	0	5	95	90	TUMOR FREE	No imaging evidence of disease	NO	NO	Complete Remission/Response	No	NO	R0		Primary Tumor	01	Sinusoid Invasion Absent					NO	YES	OR	Adrenal	A	LIVING	3	Venous Invasion Absent	2008	0e68b520-96e7-402c-a522-64995ea316a5	TCGA-OR-A5JI-01A-11D-A29H-01	TCGA-OR-A5JI-01A-11D-A29I-10	0e68b520-96e7-402c-a522-64995ea316a5	TCGA-OR-A5JI-01A-11D-A29I-10		TCGA-OR-A5JI-01A-11D-A29I-10	TCGA-OR-A5JI-01A-11D-A29J-05	d5a1b1c5-f790-4733-a8f5-09372d695688	TCGA-OR-A5JI-01A-11D-A29I-10	TCGA-OR-A5JI-01	d5a1b1c5-f790-4733-a8f5-09372d695688	d5a1b1c5-f790-4733-a8f5-09372d695688	TCGA-OR-A5JI-01	d5a1b1c5-f790-4733-a8f5-09372d695688	TCGA-OR-A5JI-01A-11D-A29H-01	TCGA-OR-A5JI-01A-11R-A29W-13	TCGA-OR-A5JI-01A-11D-A29I-10
TCGA-OR-A5JJ-01	1	TCGA-OR-A5JJ-01	490	1	TCGA-OR-A5JJ	490	0	490	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			65	Atypical Mitotic Figures Present	TCGA-OR-A5JJ-F60575	M1	Lung Involvement	Cytoplasm presence <= 25% Present	-24082	1308	490	0	309			Diffuse Architecture Present			None	2014-6-11	MALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	40	Invasion of Tumor Capsule Present	NO	Left	NO	6			50	YES	YES		Mitotic Rate > 5/50 HPF Present	YES	Necrosis Present						NO	Nuclear Grade III or IV Present	6	true	N1	T4	Stage IV	TCGA-OR-A5JJ.AF7A85AB-4C73-40B8-B913-9E540FEDE0FC.pdf	0	0	0	0	0	1	99	99	WITH TUMOR	Persistent distant metastases	YES	YES	Progressive Disease	No	NO	R2		Primary Tumor	01	Sinusoid Invasion Present	NO				NO	YES	OR	Adrenal	A	DECEASED	9	Venous Invasion Present	2009	820a642e-893a-49ed-b73a-00bceaad9edd	TCGA-OR-A5JJ-01A-11D-A29H-01	TCGA-OR-A5JJ-01A-11D-A29I-10	820a642e-893a-49ed-b73a-00bceaad9edd	TCGA-OR-A5JJ-01A-11D-A29I-10		TCGA-OR-A5JJ-01A-11D-A29I-10	TCGA-OR-A5JJ-01A-11D-A29J-05	39336e11-24de-43be-913a-c764310d1eee	TCGA-OR-A5JJ-01A-11D-A29I-10	TCGA-OR-A5JJ-01	39336e11-24de-43be-913a-c764310d1eee	39336e11-24de-43be-913a-c764310d1eee	TCGA-OR-A5JJ-01	39336e11-24de-43be-913a-c764310d1eee	TCGA-OR-A5JJ-01A-11D-A29H-01	TCGA-OR-A5JJ-01A-11R-A29W-13	TCGA-OR-A5JJ-01A-11D-A29I-10
TCGA-OR-A5JK-01	0	TCGA-OR-A5JK-01	1497	0	TCGA-OR-A5JK	1497	0	1497	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			49	Atypical Mitotic Figures Present	TCGA-OR-A5JK-F60576	M1	Lung Involvement	Cytoplasm presence <= 25% Present	-18214	1301		0	1497			Diffuse Architecture Present			None	2014-6-11	MALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	60	Invasion of Tumor Capsule Present	NO	Left	NO		Biopsy Proven		4	YES	YES		Mitotic Rate > 5/50 HPF Absent	NO	Necrosis Present						NO	Nuclear Grade III or IV Present		true	N0	T4	Stage IV	TCGA-OR-A5JK.69DBF44F-F313-423E-8DD7-E3F80AE875B8.pdf	0	0	0	0	0	1	99	99	TUMOR FREE	Persistent distant metastases	YES		Partial Remission/Response	No	YES	R2		Primary Tumor	01	Sinusoid Invasion Present	YES				NO	YES	OR	Adrenal	A	LIVING	8	Venous Invasion Present	2009	7293f226-7455-428c-b603-9050a23c9742	TCGA-OR-A5JK-01A-11D-A29H-01	TCGA-OR-A5JK-01A-11D-A29I-10	7293f226-7455-428c-b603-9050a23c9742	TCGA-OR-A5JK-01A-11D-A29I-10		TCGA-OR-A5JK-01A-11D-A29I-10	TCGA-OR-A5JK-01A-11D-A29J-05	db5bc4cb-f0bc-4c26-bd11-1bf918466263	TCGA-OR-A5JK-01A-11D-A29I-10	TCGA-OR-A5JK-01	db5bc4cb-f0bc-4c26-bd11-1bf918466263	db5bc4cb-f0bc-4c26-bd11-1bf918466263	TCGA-OR-A5JK-01	db5bc4cb-f0bc-4c26-bd11-1bf918466263	TCGA-OR-A5JK-01A-11D-A29H-01	TCGA-OR-A5JK-01A-11R-A29W-13	TCGA-OR-A5JK-01A-11D-A29I-10
TCGA-OR-A5JL-01	0	TCGA-OR-A5JL-01	670	0	TCGA-OR-A5JL	670	0	670	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			36	Atypical Mitotic Figures Present	TCGA-OR-A5JL-F60577	M0	Normal	Cytoplasm presence <= 25% Present	-13155	1224		0	670			Diffuse Architecture Present		Both Clinical and Biochemical Assessments	Androgen	2014-6-11	FEMALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	60	Invasion of Tumor Capsule Absent	NO	Right	NO				6	YES	YES		Mitotic Rate > 5/50 HPF Present	NO	Necrosis Absent						NO	Nuclear Grade III or IV Present		true	N0	T1	Stage I	TCGA-OR-A5JL.BD8435C3-C525-472C-8B43-EC2CAE22B785.pdf	0	0	0	0	0	0	100	97	TUMOR FREE	No imaging evidence of disease	YES	NO	Complete Remission/Response	No	NO	R0		Primary Tumor	01	Sinusoid Invasion Absent	YES				NO	YES	OR	Adrenal	A	LIVING	5	Venous Invasion Absent	2009	f70dee4f-4b68-46e2-8734-ad3b59507552	TCGA-OR-A5JL-01A-11D-A29H-01	TCGA-OR-A5JL-01A-11D-A29I-10	f70dee4f-4b68-46e2-8734-ad3b59507552	TCGA-OR-A5JL-01A-11D-A29I-10		TCGA-OR-A5JL-01A-11D-A29I-10	TCGA-OR-A5JL-01A-11D-A29J-05	3e28c232-4f00-446e-8e2c-13b7ce533442	TCGA-OR-A5JL-01A-11D-A29I-10	TCGA-OR-A5JL-01	3e28c232-4f00-446e-8e2c-13b7ce533442	3e28c232-4f00-446e-8e2c-13b7ce533442	TCGA-OR-A5JL-01	3e28c232-4f00-446e-8e2c-13b7ce533442	TCGA-OR-A5JL-01A-11D-A29H-01	TCGA-OR-A5JL-01A-11R-A29W-13	TCGA-OR-A5JL-01A-11D-A29I-10
TCGA-OR-A5JM-01	1	TCGA-OR-A5JM-01	562	1	TCGA-OR-A5JM			562	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			25	Atypical Mitotic Figures Present		M1	Liver Involvement	Cytoplasm presence <= 25% Present	-9359	657	562	0				Diffuse Architecture Present		Both Clinical and Biochemical Assessments	Cortisol	2013-10-3	FEMALE		Adrenocortical carcinoma- Usual Type	Yes	C74.0	8370/3	C74.0	YES	70	Invasion of Tumor Capsule Present	NO	Left			Other, specify		90	YES	YES		Mitotic Rate > 5/50 HPF Present	NO	Necrosis Present						YES	Nuclear Grade III or IV Present		true	N0	T4	Stage IV	TCGA-OR-A5JM.A214150E-54BD-499D-A56D-082BAC861668.pdf	0	0	17	0	0	0	83	95	WITH TUMOR	Biochemical Evidence of Disease	YES		Progressive Disease	No	YES	R1		Primary Tumor	01	Sinusoid Invasion Present					NO	YES	OR	Adrenal	A	DECEASED	9	Venous Invasion Present	2011	31c0a89c-deca-4a99-8c8d-ff0a4152cc40	TCGA-OR-A5JM-01A-11D-A29H-01	TCGA-OR-A5JM-01A-11D-A29I-10	31c0a89c-deca-4a99-8c8d-ff0a4152cc40	TCGA-OR-A5JM-01A-11D-A29I-10		TCGA-OR-A5JM-01A-11D-A29I-10	TCGA-OR-A5JM-01A-11D-A29J-05	908285b8-1e2e-4aed-86df-2aaeb1bcefea	TCGA-OR-A5JM-01A-11D-A29I-10	TCGA-OR-A5JM-01	908285b8-1e2e-4aed-86df-2aaeb1bcefea	908285b8-1e2e-4aed-86df-2aaeb1bcefea	TCGA-OR-A5JM-01	908285b8-1e2e-4aed-86df-2aaeb1bcefea	TCGA-OR-A5JM-01A-11D-A29H-01	TCGA-OR-A5JM-01A-11R-A29W-13	TCGA-OR-A5JM-01A-11D-A29I-10
TCGA-OR-A5JO-01	0	TCGA-OR-A5JO-01	889	0	TCGA-OR-A5JO	889	0	889	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			26	Atypical Mitotic Figures Absent	TCGA-OR-A5JO-F60578	M0	Normal	Cytoplasm presence <= 25% Absent	-9547	2773		0	889			Diffuse Architecture Present			None	2014-6-11	FEMALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	20	Invasion of Tumor Capsule Absent	NO	Right	NO				2	NO	NO		Mitotic Rate > 5/50 HPF Absent	NO	Necrosis Absent						NO	Nuclear Grade III or IV Present		true	N0	T1	Stage I	TCGA-OR-A5JO.1FECADEA-0B65-451D-933D-2217F9119D35.pdf	5	0	0	0	0	5	95	90	TUMOR FREE	No imaging evidence of disease	NO	NO	Complete Remission/Response	No	NO	R0		Primary Tumor	01	Sinusoid Invasion Absent					NO	YES	OR	Adrenal	A	LIVING	3	Venous Invasion Present	2005	92c2b675-7566-43d6-bfff-71f0a793d95a	TCGA-OR-A5JO-01A-11D-A29H-01	TCGA-OR-A5JO-01A-11D-A29I-10	92c2b675-7566-43d6-bfff-71f0a793d95a	TCGA-OR-A5JO-01A-11D-A29I-10		TCGA-OR-A5JO-01A-11D-A29I-10	TCGA-OR-A5JO-01A-11D-A29J-05	ebc120e7-d75d-425a-b9af-aa0e76520642	TCGA-OR-A5JO-01A-11D-A29I-10	TCGA-OR-A5JO-01	ebc120e7-d75d-425a-b9af-aa0e76520642	ebc120e7-d75d-425a-b9af-aa0e76520642	TCGA-OR-A5JO-01	ebc120e7-d75d-425a-b9af-aa0e76520642	TCGA-OR-A5JO-01A-11D-A29H-01	TCGA-OR-A5JO-01A-11R-A29W-13	TCGA-OR-A5JO-01A-11D-A29I-10
TCGA-OR-A5JP-01	0	TCGA-OR-A5JP-01	464	0	TCGA-OR-A5JP	464	0	464	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			40	Atypical Mitotic Figures Present	TCGA-OR-A5JP-F60579	M0	Normal	Cytoplasm presence <= 25% Present	-14667	289		0	464			Diffuse Architecture Present			None	2014-6-11	MALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	60	Invasion of Tumor Capsule Absent	NO	Left	NO				13	YES	YES		Mitotic Rate > 5/50 HPF Present	NO	Necrosis Present						NO	Nuclear Grade III or IV Present		true	N0	T2	Stage II	TCGA-OR-A5JP.E7B0A3CF-35A3-433C-AF76-DB3E28DA6A46.pdf	0	0	0	0	0	0	100	95	TUMOR FREE	No imaging evidence of disease	YES	NO	Complete Remission/Response	No	NO	R0		Primary Tumor	01	Sinusoid Invasion Absent	YES				NO	YES	OR	Adrenal	A	LIVING	6	Venous Invasion Absent	2012	e79049b4-162c-40c3-b550-d4961c03fa52	TCGA-OR-A5JP-01A-11D-A29H-01	TCGA-OR-A5JP-01A-11D-A29I-10	e79049b4-162c-40c3-b550-d4961c03fa52	TCGA-OR-A5JP-01A-11D-A29I-10	FD2E1526-5455-40FA-8AE2-15C5FF2BAA65	TCGA-OR-A5JP-01A-11D-A29I-10	TCGA-OR-A5JP-01A-11D-A29J-05	49e3ffbc-f75f-4f3d-99de-12c29ef69154	TCGA-OR-A5JP-01A-11D-A29I-10	TCGA-OR-A5JP-01	49e3ffbc-f75f-4f3d-99de-12c29ef69154	49e3ffbc-f75f-4f3d-99de-12c29ef69154	TCGA-OR-A5JP-01	49e3ffbc-f75f-4f3d-99de-12c29ef69154	TCGA-OR-A5JP-01A-11D-A29H-01	TCGA-OR-A5JP-01A-11R-A29W-13	TCGA-OR-A5JP-01A-11D-A29I-10
TCGA-OR-A5JQ-01	0	TCGA-OR-A5JQ-01	1103	0	TCGA-OR-A5JQ	1103	0	1103	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			26	Atypical Mitotic Figures Absent	TCGA-OR-A5JQ-F60580	M0	Normal	Cytoplasm presence <= 25% Present	-9667	2520		0	1103			Diffuse Architecture Present			None	2014-6-11	FEMALE		Adrenocortical Carcinoma- Myxoid Type	No	C74.0	8370/3	C74.0	YES	40	Invasion of Tumor Capsule Absent	NO	Right	NO				3	NO	NO		Mitotic Rate > 5/50 HPF Absent	NO	Necrosis Absent						NO	Nuclear Grade III or IV Present		true	N0	T2	Stage II	TCGA-OR-A5JQ.3AE0E638-5907-4B56-9C55-E58D97B27AFF.pdf	0	0	0	0	0	0	100	95	TUMOR FREE	No imaging evidence of disease	NO	NO	Complete Remission/Response	No	NO	R0		Primary Tumor	01	Sinusoid Invasion Present					NO	YES	OR	Adrenal	A	LIVING	4	Venous Invasion Absent	2006	17decefd-123d-41be-ad0a-9c27ed5f1f16	TCGA-OR-A5JQ-01A-11D-A29H-01	TCGA-OR-A5JQ-01A-11D-A29I-10	17decefd-123d-41be-ad0a-9c27ed5f1f16	TCGA-OR-A5JQ-01A-11D-A29I-10		TCGA-OR-A5JQ-01A-11D-A29I-10	TCGA-OR-A5JQ-01A-11D-A29J-05	f0461f9a-e85e-42c6-8f4b-e5974a0e78f8	TCGA-OR-A5JQ-01A-11D-A29I-10	TCGA-OR-A5JQ-01	f0461f9a-e85e-42c6-8f4b-e5974a0e78f8	f0461f9a-e85e-42c6-8f4b-e5974a0e78f8	TCGA-OR-A5JQ-01	f0461f9a-e85e-42c6-8f4b-e5974a0e78f8	TCGA-OR-A5JQ-01A-11D-A29H-01	TCGA-OR-A5JQ-01A-11R-A29W-13	TCGA-OR-A5JQ-01A-11D-A29I-10
TCGA-OR-A5JR-01	0	TCGA-OR-A5JR-01	3688	0	TCGA-OR-A5JR	3688	0	3688	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			45		TCGA-OR-A5JR-F59158	M0			-16604	3751		0	3688			Diffuse Architecture Absent			None	2014-5-2	MALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	80	Invasion of Tumor Capsule Present	NO	Left	YES					NO				YES	Necrosis Absent						NO	Nuclear Grade III or IV Absent		false	N0	T1	Stage I	TCGA-OR-A5JR.33E0DEF4-2538-4C8B-A71C-11B4F9D57E32.pdf	0	0	0	0	0	15	85	85	TUMOR FREE	No imaging evidence of disease	NO	NO	Complete Remission/Response	No	NO	R0		Primary Tumor	01	Sinusoid Invasion Absent					NO	YES	OR	Adrenal	A	LIVING		Venous Invasion Absent	2002	36250bb2-38da-4c65-b287-ae4757a07fec	TCGA-OR-A5JR-01A-11D-A29H-01	TCGA-OR-A5JR-01A-11D-A29I-10	36250bb2-38da-4c65-b287-ae4757a07fec	TCGA-OR-A5JR-01A-11D-A29I-10	8DCC0B31-4CD4-4537-8BC1-C928F1E5BB29	TCGA-OR-A5JR-01A-11D-A29I-10	TCGA-OR-A5JR-01A-11D-A29J-05	cc3d79b1-66a4-4f17-bdb1-c91ffab17037	TCGA-OR-A5JR-01A-11D-A29I-10	TCGA-OR-A5JR-01	cc3d79b1-66a4-4f17-bdb1-c91ffab17037	cc3d79b1-66a4-4f17-bdb1-c91ffab17037	TCGA-OR-A5JR-01	cc3d79b1-66a4-4f17-bdb1-c91ffab17037	TCGA-OR-A5JR-01A-11D-A29H-01	TCGA-OR-A5JR-01A-11R-A29W-13	TCGA-OR-A5JR-01A-11D-A29I-10
TCGA-OR-A5JS-01	0	TCGA-OR-A5JS-01	383	0	TCGA-OR-A5JS	166	1	383	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer	YES	NO	65		TCGA-OR-A5JS-F59160	M0	Normal		-24017	699		0	383		166				None	2014-5-2	FEMALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	150	Invasion of Tumor Capsule Absent	NO	Right	YES				35	NO			Mitotic Rate > 5/50 HPF Present	NO	Necrosis Present	Imaging	Lung	Distant Metastasis		NO	YES			false	N0	T2	Stage II	TCGA-OR-A5JS.B6E65697-5AE8-45B4-9FAA-D25B8F57988F.pdf	2	0	0	0	0	15	85	85	WITH TUMOR	No imaging evidence of disease	NO	NO		No	YES	R0		Primary Tumor	01						NO	YES	OR	Adrenal	A	LIVING			2011	c45a32aa-07e5-43d9-84f0-4e0aac523f92	TCGA-OR-A5JS-01A-11D-A29H-01	TCGA-OR-A5JS-01A-11D-A29I-10	c45a32aa-07e5-43d9-84f0-4e0aac523f92	TCGA-OR-A5JS-01A-11D-A29I-10	D187AC75-482F-454F-851A-10A7ABEBA2BF	TCGA-OR-A5JS-01A-11D-A29I-10	TCGA-OR-A5JS-01A-11D-A29J-05	68b2e310-e0a0-4867-b9cf-69b43cbdabce	TCGA-OR-A5JS-01A-11D-A29I-10	TCGA-OR-A5JS-01	68b2e310-e0a0-4867-b9cf-69b43cbdabce	68b2e310-e0a0-4867-b9cf-69b43cbdabce	TCGA-OR-A5JS-01	68b2e310-e0a0-4867-b9cf-69b43cbdabce	TCGA-OR-A5JS-01A-11D-A29H-01	TCGA-OR-A5JS-01A-11R-A29W-13	TCGA-OR-A5JS-01A-11D-A29I-10
TCGA-OR-A5JT-01	0	TCGA-OR-A5JT-01	907	0	TCGA-OR-A5JT	907	0	907	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			65		TCGA-OR-A5JT-F59161	M0	Normal		-23794	419		0	907					Biochemical Assessment	Cortisol	2014-5-1	FEMALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	140	Invasion of Tumor Capsule Absent	NO	Left	NO	17			5	YES	YES		Mitotic Rate > 5/50 HPF Absent	YES	Necrosis Present						NO		0	false	N0	T2	Stage II	TCGA-OR-A5JT.095AE671-9808-4895-B6FD-EDA3F7F9E69D.pdf	0	0	0	0	0	10	90	90	WITH TUMOR	No imaging evidence of disease	YES	YES	Stable Disease	No	YES	R0		Primary Tumor	01		YES			YES	NO	YES	OR	Adrenal	A	LIVING		Venous Invasion Absent	2011	26a14093-45da-4f34-b8c9-b2f09c44f845	TCGA-OR-A5JT-01A-11D-A29H-01	TCGA-OR-A5JT-01A-11D-A29I-10	26a14093-45da-4f34-b8c9-b2f09c44f845	TCGA-OR-A5JT-01A-11D-A29I-10	C9D2DE61-07C2-4BE8-832F-D4D95749A075	TCGA-OR-A5JT-01A-11D-A29I-10	TCGA-OR-A5JT-01A-11D-A29J-05	36c36f8f-d15b-43be-a285-1f80fcfff555	TCGA-OR-A5JT-01A-11D-A29I-10	TCGA-OR-A5JT-01	36c36f8f-d15b-43be-a285-1f80fcfff555	36c36f8f-d15b-43be-a285-1f80fcfff555	TCGA-OR-A5JT-01	36c36f8f-d15b-43be-a285-1f80fcfff555	TCGA-OR-A5JT-01A-11D-A29H-01	TCGA-OR-A5JT-01A-11R-A29W-13	TCGA-OR-A5JT-01A-11D-A29I-10
TCGA-OR-A5JU-01	1	TCGA-OR-A5JU-01	289	1	TCGA-OR-A5JU			289	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			58			M0	Normal		-21292	749	289	0							None	2014-2-6	FEMALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	130	Invasion of Tumor Capsule Present	NO	Right					10	YES	YES	NO	Mitotic Rate > 5/50 HPF Present	YES	Necrosis Absent						YES			false	N0	T3	Stage III	TCGA-OR-A5JU.2D791779-66E6-408C-B479-CC74246F0EA8.pdf	2	0	0	0	0	15	85	85	WITH TUMOR	No imaging evidence of disease	YES	NO	Progressive Disease	No	YES	R0		Primary Tumor	01						NO	YES	OR	Adrenal	A	DECEASED		Venous Invasion Absent	2010	4af0c84b-1bc8-4dc8-bb84-423346eba2d6	TCGA-OR-A5JU-01A-11D-A309-01	TCGA-OR-A5JU-01A-11D-A30A-10	4af0c84b-1bc8-4dc8-bb84-423346eba2d6	TCGA-OR-A5JU-01A-11D-A30A-10		TCGA-OR-A5JU-01A-11D-A30A-10			TCGA-OR-A5JU-01A-11D-A30A-10						TCGA-OR-A5JU-01A-11D-A309-01		TCGA-OR-A5JU-01A-11D-A30A-10
TCGA-OR-A5JV-01	0	TCGA-OR-A5JV-01	2023	0	TCGA-OR-A5JV	2023	0	2023	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			55		TCGA-OR-A5JV-F59162	M0	Normal		-20319	1696		0	2023						None	2014-5-1	MALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	110	Invasion of Tumor Capsule Absent	NO	Left	NO	1				YES	YES				Necrosis Absent						NO		0	false	N0	T2	Stage II	TCGA-OR-A5JV.35A41AE5-44E3-45D1-A2C0-523496732A75.pdf	2	0	0	0	0	15	85	85	TUMOR FREE	No imaging evidence of disease	YES	YES	Complete Remission/Response	No	NO	R0		Primary Tumor	01		YES			NO	NO	YES	OR	Adrenal	A	LIVING		Venous Invasion Absent	2008	d4ee0ec3-7a9c-4f8d-80a8-c3a758916f01	TCGA-OR-A5JV-01A-11D-A29H-01	TCGA-OR-A5JV-01A-11D-A29I-10	d4ee0ec3-7a9c-4f8d-80a8-c3a758916f01	TCGA-OR-A5JV-01A-11D-A29I-10	148E70D8-63E9-421C-9D54-EB905B6EE954	TCGA-OR-A5JV-01A-11D-A29I-10	TCGA-OR-A5JV-01A-11D-A29J-05	20938e21-2846-4553-98eb-6b005b6600c3	TCGA-OR-A5JV-01A-11D-A29I-10	TCGA-OR-A5JV-01	20938e21-2846-4553-98eb-6b005b6600c3	20938e21-2846-4553-98eb-6b005b6600c3	TCGA-OR-A5JV-01	20938e21-2846-4553-98eb-6b005b6600c3	TCGA-OR-A5JV-01A-11D-A29H-01	TCGA-OR-A5JV-01A-11R-A29W-13	TCGA-OR-A5JV-01A-11D-A29I-10
TCGA-OR-A5JW-01	0	TCGA-OR-A5JW-01	2202	0	TCGA-OR-A5JW	2202	0	2202	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			47		TCGA-OR-A5JW-F59163	M0	Normal		-17513	1713		0	2202					Both Clinical and Biochemical Assessments	Cortisol	2014-5-1	MALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	140		NO	Right	NO					YES	YES				Necrosis Present						NO			false	N0	T2	Stage II	TCGA-OR-A5JW.54BAF12C-F096-4415-BFF0-DD35D22E932B.pdf	1	0	0	0	0	10	90	100	TUMOR FREE	No imaging evidence of disease	YES	NO	Complete Remission/Response	No	YES	R0		Primary Tumor	01		YES				NO	YES	OR	Adrenal	A	LIVING			2008	8cb9f38a-147a-47d0-a631-a1a1cca4c118	TCGA-OR-A5JW-01A-11D-A29H-01	TCGA-OR-A5JW-01A-11D-A29I-10	8cb9f38a-147a-47d0-a631-a1a1cca4c118	TCGA-OR-A5JW-01A-11D-A29I-10	7ABAE497-21E0-4DA6-B835-5E60E4E2878F	TCGA-OR-A5JW-01A-11D-A29I-10	TCGA-OR-A5JW-01A-11D-A29J-05	a499a77e-4584-4cab-a7d9-3d0b42ed4dd8	TCGA-OR-A5JW-01A-11D-A29I-10	TCGA-OR-A5JW-01	a499a77e-4584-4cab-a7d9-3d0b42ed4dd8	a499a77e-4584-4cab-a7d9-3d0b42ed4dd8	TCGA-OR-A5JW-01	a499a77e-4584-4cab-a7d9-3d0b42ed4dd8	TCGA-OR-A5JW-01A-11D-A29H-01	TCGA-OR-A5JW-01A-11R-A29W-13	TCGA-OR-A5JW-01A-11D-A29I-10
TCGA-OR-A5JX-01	0	TCGA-OR-A5JX-01	950	0	TCGA-OR-A5JX	950	0	950	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			50		TCGA-OR-A5JX-F59164	M0			-18402	1162		0	950						None	2014-5-2	MALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	120	Invasion of Tumor Capsule Present	NO	Left	YES	1			5	YES	YES		Mitotic Rate > 5/50 HPF Absent	YES	Necrosis Present						NO		0	false	N0	T3	Stage III	TCGA-OR-A5JX.6F548B5E-C4A2-46C7-8B56-7DD037CC49B5.pdf	0	0	0	0	0	5	95	100	TUMOR FREE	No imaging evidence of disease	YES	YES		No	YES	R0		Primary Tumor	01		YES			NO	NO	YES	OR	Adrenal	A	LIVING		Venous Invasion Present	2009	4ab4aa74-991a-43e6-af3e-afb71e7bbc6c	TCGA-OR-A5JX-01A-11D-A29H-01	TCGA-OR-A5JX-01A-11D-A29I-10	4ab4aa74-991a-43e6-af3e-afb71e7bbc6c	TCGA-OR-A5JX-01A-11D-A29I-10		TCGA-OR-A5JX-01A-11D-A29I-10	TCGA-OR-A5JX-01A-11D-A29J-05	7fae0485-2028-47e3-a3e1-248257fcc02e	TCGA-OR-A5JX-01A-11D-A29I-10	TCGA-OR-A5JX-01	7fae0485-2028-47e3-a3e1-248257fcc02e	7fae0485-2028-47e3-a3e1-248257fcc02e	TCGA-OR-A5JX-01	7fae0485-2028-47e3-a3e1-248257fcc02e	TCGA-OR-A5JX-01A-11D-A29H-01	TCGA-OR-A5JX-01A-11R-A29W-13	TCGA-OR-A5JX-01A-11D-A29I-10
TCGA-OR-A5JY-01	1	TCGA-OR-A5JY-01	552	1	TCGA-OR-A5JY			552	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			68			M1	Vena Cava Involvement/thrombus		-25190	414	552	0						Both Clinical and Biochemical Assessments	Androgen|Cortisol	2013-9-10	FEMALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	190	Invasion of Tumor Capsule Present	NO	Right		2	Other, specify	surgical resection	60	YES	NO	YES	Mitotic Rate > 5/50 HPF Present		Necrosis Present						YES		1	false	N1	T4	Stage IV	TCGA-OR-A5JY.8D4E0E4D-9C84-4F29-AFD9-91EEEC158ED6.pdf	0	0	20	0	0	0	80	90	WITH TUMOR	Persistent distant metastases	YES	YES	Progressive Disease	No	YES	R2		Primary Tumor	01			NO			NO	YES	OR	Adrenal	A	DECEASED		Venous Invasion Present	2011	b8e37eaf-3103-4ff1-880b-fdd0923c2537	TCGA-OR-A5JY-01A-31D-A29H-01	TCGA-OR-A5JY-01A-31D-A29I-10	b8e37eaf-3103-4ff1-880b-fdd0923c2537	TCGA-OR-A5JY-01A-31D-A29I-10	A4ABDBE6-DB86-40C9-8E65-E772D0B6AB28	TCGA-OR-A5JY-01A-31D-A29I-10	TCGA-OR-A5JY-01A-31D-A29J-05	1fe73f5c-591d-4c55-ae0e-a67afb64f872	TCGA-OR-A5JY-01A-31D-A29I-10	TCGA-OR-A5JY-01	1fe73f5c-591d-4c55-ae0e-a67afb64f872	1fe73f5c-591d-4c55-ae0e-a67afb64f872	TCGA-OR-A5JY-01	1fe73f5c-591d-4c55-ae0e-a67afb64f872	TCGA-OR-A5JY-01A-31D-A29H-01	TCGA-OR-A5JY-01A-31R-A29W-13	TCGA-OR-A5JY-01A-31D-A29I-10
TCGA-OR-A5JZ-01	0	TCGA-OR-A5JZ-01	822	0	TCGA-OR-A5JZ	247	1	822	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer	YES	NO	60		TCGA-OR-A5JZ-F59165	M0	Normal		-22218	373		0	822		247				None	2014-5-1	MALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	130	Invasion of Tumor Capsule Present	NO	Left	NO				5	YES	YES		Mitotic Rate > 5/50 HPF Absent	YES	Necrosis Present	Imaging	Liver	Distant Metastasis		NO	YES			false	N0	T2	Stage II	TCGA-OR-A5JZ.90A9556D-C417-4FDB-AE1C-7ACB9F60E444.pdf	1	1	1	0	0	4	95	100	WITH TUMOR	No imaging evidence of disease	YES	NO	Progressive Disease	No	YES	R0		Primary Tumor	01		NO				NO	YES	OR	Adrenal	A	LIVING		Venous Invasion Absent	2011	321dab35-c61e-45b9-8af4-17ab9275da5b	TCGA-OR-A5JZ-01A-11D-A29H-01	TCGA-OR-A5JZ-01A-11D-A29I-10	321dab35-c61e-45b9-8af4-17ab9275da5b	TCGA-OR-A5JZ-01A-11D-A29I-10	47A9E07A-5319-4550-98C8-B48E1785E8B9	TCGA-OR-A5JZ-01A-11D-A29I-10	TCGA-OR-A5JZ-01A-11D-A29J-05	efd8ce67-122c-4502-8713-2f4dd768c33d	TCGA-OR-A5JZ-01A-11D-A29I-10	TCGA-OR-A5JZ-01	efd8ce67-122c-4502-8713-2f4dd768c33d	efd8ce67-122c-4502-8713-2f4dd768c33d	TCGA-OR-A5JZ-01	efd8ce67-122c-4502-8713-2f4dd768c33d	TCGA-OR-A5JZ-01A-11D-A29H-01	TCGA-OR-A5JZ-01A-11R-A29W-13	TCGA-OR-A5JZ-01A-11D-A29I-10
TCGA-OR-A5K0-01	0	TCGA-OR-A5K0-01	1029	0	TCGA-OR-A5K0			1029	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			69		TCGA-OR-A5K0-F59166	M0	Normal		-25400	1097		0	1029					Biochemical Assessment	Cortisol	2014-5-2	FEMALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	200	Invasion of Tumor Capsule Present	NO	Left	YES				8	NO			Mitotic Rate > 5/50 HPF Present		Necrosis Present						YES			false	N0	T2	Stage II	TCGA-OR-A5K0.4E5C6CF0-F346-4ECE-B296-0D2DB4513804.pdf	0	0	20	0	0	10	70	100	WITH TUMOR	No imaging evidence of disease	NO	NO	Progressive Disease	Yes	NO	R0		Primary Tumor	01						NO	YES	OR	Adrenal	A	LIVING		Venous Invasion Absent	2009	07723492-863e-44a2-9b69-6385e30671c9	TCGA-OR-A5K0-01A-11D-A29H-01	TCGA-OR-A5K0-01A-11D-A29I-10	07723492-863e-44a2-9b69-6385e30671c9	TCGA-OR-A5K0-01A-11D-A29I-10	0C923154-7872-4AEE-A56A-085CCD06E6BC	TCGA-OR-A5K0-01A-11D-A29I-10	TCGA-OR-A5K0-01A-11D-A29J-05	e1434398-dde0-4855-adc1-24c2956d817a	TCGA-OR-A5K0-01A-11D-A29I-10	TCGA-OR-A5K0-01	e1434398-dde0-4855-adc1-24c2956d817a	e1434398-dde0-4855-adc1-24c2956d817a	TCGA-OR-A5K0-01	e1434398-dde0-4855-adc1-24c2956d817a	TCGA-OR-A5K0-01A-11D-A29H-01	TCGA-OR-A5K0-01A-11R-A29W-13	TCGA-OR-A5K0-01A-11D-A29I-10
TCGA-OR-A5K1-01	0	TCGA-OR-A5K1-01	2938	0	TCGA-OR-A5K1	826	1	2938	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer	NO	YES	48		TCGA-OR-A5K1-F59167	M0	Retroperitoneal Lymph Node Involvement		-17596	2513		0	2938	883	826				None	2014-5-1	MALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	150	Invasion of Tumor Capsule Present	NO	Left	NO					NO	NO					Imaging	Peritoneal Surfaces	Locoregional Recurrence		YES	YES			false	N0	T2	Stage II	TCGA-OR-A5K1.54EFE89F-32E0-4E95-A841-728648D9D11E.pdf	0	0	0	0	0	5	95	100	TUMOR FREE	No imaging evidence of disease	NO	NO	Progressive Disease	No	NO	RX		Primary Tumor	01						NO	YES	OR	Adrenal	A	LIVING			2006	5ac92f02-d9d6-4b89-bc87-764a0a9b1c10	TCGA-OR-A5K1-01A-11D-A29H-01	TCGA-OR-A5K1-01A-11D-A29I-10	5ac92f02-d9d6-4b89-bc87-764a0a9b1c10	TCGA-OR-A5K1-01A-11D-A29I-10	3C6CBE32-CF86-40FC-BF24-560A66EF7CC6	TCGA-OR-A5K1-01A-11D-A29I-10	TCGA-OR-A5K1-01A-11D-A29J-05	b6c575a4-ebbc-413d-955d-bb3c46ec50c2	TCGA-OR-A5K1-01A-11D-A29I-10	TCGA-OR-A5K1-01	b6c575a4-ebbc-413d-955d-bb3c46ec50c2	b6c575a4-ebbc-413d-955d-bb3c46ec50c2	TCGA-OR-A5K1-01	b6c575a4-ebbc-413d-955d-bb3c46ec50c2	TCGA-OR-A5K1-01A-11D-A29H-01	TCGA-OR-A5K1-01A-11R-A29W-13	TCGA-OR-A5K1-01A-11D-A29I-10
TCGA-OR-A5K2-01	1	TCGA-OR-A5K2-01	994	1	TCGA-OR-A5K2			994	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			32			M0	Normal		-11970	810	994	0						Both Clinical and Biochemical Assessments	Androgen|Cortisol	2013-9-10	FEMALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	150	Invasion of Tumor Capsule Present	NO	Right		1	Imaging Suspected		51	YES	YES	YES	Mitotic Rate > 5/50 HPF Present	YES	Necrosis Present						YES		0	false	N0	T4	Stage III	TCGA-OR-A5K2.F6CEA42D-A107-4942-B6FE-1C529D124337.pdf	0	0	0	0	0	5	95	100	WITH TUMOR	Persistent distant metastases	YES	YES	Progressive Disease	No	YES	R0		Primary Tumor	01		YES			NO	NO	YES	OR	Adrenal	A	DECEASED		Venous Invasion Present	2010	740ed154-d2e9-41cb-ad4f-db90423f4d6c	TCGA-OR-A5K2-01A-11D-A29H-01	TCGA-OR-A5K2-01A-11D-A29I-10	740ed154-d2e9-41cb-ad4f-db90423f4d6c	TCGA-OR-A5K2-01A-11D-A29I-10			TCGA-OR-A5K2-01A-11D-A29J-05	e85fc5ec-7838-46c3-8767-a69f765b066d	TCGA-OR-A5K2-01A-11D-A29I-10	TCGA-OR-A5K2-01	e85fc5ec-7838-46c3-8767-a69f765b066d	e85fc5ec-7838-46c3-8767-a69f765b066d	TCGA-OR-A5K2-01	e85fc5ec-7838-46c3-8767-a69f765b066d	TCGA-OR-A5K2-01A-11D-A29H-01	TCGA-OR-A5K2-01A-11R-A29W-13	TCGA-OR-A5K2-01A-11D-A29I-10
TCGA-OR-A5K3-01	0	TCGA-OR-A5K3-01	3047	0	TCGA-OR-A5K3	3047	0	3047	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			53		TCGA-OR-A5K3-F59168	M0	Normal		-19375	2646		0	3047						None	2014-5-1	MALE		Adrenocortical Carcinoma- Oncocytic Type	No	C74.0	8370/3	C74.0	YES	110	Invasion of Tumor Capsule Present	NO	Left	NO					NO	NO			NO	Necrosis Present						NO			false	N0	T2	Stage II	TCGA-OR-A5K3.718C16E9-A099-4F21-A48E-A97B464A9422.pdf	0	0	2	0	0	10	88	100	TUMOR FREE	No imaging evidence of disease	NO	NO	Complete Remission/Response	No	NO	R0		Primary Tumor	01						NO	YES	OR	Adrenal	A	LIVING			2005	c6d8fc41-c1b5-457f-a769-7ad898fdb889	TCGA-OR-A5K3-01A-11D-A29H-01	TCGA-OR-A5K3-01A-11D-A29I-10	c6d8fc41-c1b5-457f-a769-7ad898fdb889	TCGA-OR-A5K3-01A-11D-A29I-10	08E6497A-47F5-4283-A534-7C04EEC936E9		TCGA-OR-A5K3-01A-11D-A29J-05	61d60013-6ffd-4c08-b03f-a8820db32397	TCGA-OR-A5K3-01A-11D-A29I-10	TCGA-OR-A5K3-01	61d60013-6ffd-4c08-b03f-a8820db32397	61d60013-6ffd-4c08-b03f-a8820db32397	TCGA-OR-A5K3-01	61d60013-6ffd-4c08-b03f-a8820db32397	TCGA-OR-A5K3-01A-11D-A29H-01	TCGA-OR-A5K3-01A-11R-A29W-13	TCGA-OR-A5K3-01A-11D-A29I-10
TCGA-OR-A5K4-01	0	TCGA-OR-A5K4-01	699	0	TCGA-OR-A5K4	699	0	699	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			64		TCGA-OR-A5K4-F59169	M0	Vena Cava Involvement/thrombus		-23481	362		0	699						None	2014-5-1	FEMALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	190	Invasion of Tumor Capsule Absent	NO	Right	NO				2	YES	YES		Mitotic Rate > 5/50 HPF Absent	YES	Necrosis Present						NO			false	N0	T4	Stage III	TCGA-OR-A5K4.15A731FD-6B89-450D-A02B-A01DA759340A.pdf	0	0	0	0	0	0	100	97	TUMOR FREE	No imaging evidence of disease	YES	NO	Complete Remission/Response	No	YES	R1		Primary Tumor	01		NO				NO	YES	OR	Adrenal	A	LIVING		Venous Invasion Present	2011	516b3003-bda5-4b94-896a-5da9458b7570	TCGA-OR-A5K4-01A-11D-A29H-01	TCGA-OR-A5K4-01A-11D-A29I-10	516b3003-bda5-4b94-896a-5da9458b7570	TCGA-OR-A5K4-01A-11D-A29I-10	A2831971-C497-4E23-A84C-B2D64B21E72C	TCGA-OR-A5K4-01A-11D-A29I-10	TCGA-OR-A5K4-01A-11D-A29J-05	5c9ae88c-353f-450b-80e6-8d36d7bc8be3	TCGA-OR-A5K4-01A-11D-A29I-10	TCGA-OR-A5K4-01	5c9ae88c-353f-450b-80e6-8d36d7bc8be3	5c9ae88c-353f-450b-80e6-8d36d7bc8be3	TCGA-OR-A5K4-01	5c9ae88c-353f-450b-80e6-8d36d7bc8be3	TCGA-OR-A5K4-01A-11D-A29H-01	TCGA-OR-A5K4-01A-11R-A29W-13	TCGA-OR-A5K4-01A-11D-A29I-10
TCGA-OR-A5K5-01	1	TCGA-OR-A5K5-01	498	1	TCGA-OR-A5K5	108	1	498	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer	YES	NO	59		TCGA-OR-A5K5-F59170	M0	Normal		-21907	34	498	0	253		108			Both Clinical and Biochemical Assessments	Androgen|Cortisol	2014-5-1	FEMALE	NO	Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	120	Invasion of Tumor Capsule Present	NO	Left	NO	20			31	YES	YES		Mitotic Rate > 5/50 HPF Present	YES	Necrosis Present	Imaging	Lung	Distant Metastasis		NO	YES		0	false	N0	T3	Stage III	TCGA-OR-A5K5.6EA3FB77-3DD4-43C8-8C39-CA8755EBC50C.pdf	0	0	5	0	0	5	90	90	WITH TUMOR		YES	YES	Progressive Disease	No	YES	R0		Primary Tumor	01		YES			NO	NO	YES	OR	Adrenal	A	DECEASED		Venous Invasion Present	2012	b50c051b-5569-418c-8b3d-5dde7eb77824	TCGA-OR-A5K5-01A-11D-A29H-01	TCGA-OR-A5K5-01A-11D-A29I-10	b50c051b-5569-418c-8b3d-5dde7eb77824	TCGA-OR-A5K5-01A-11D-A29I-10	D0C57FBD-20EE-4113-A135-7B7617304C0F	TCGA-OR-A5K5-01A-11D-A29I-10	TCGA-OR-A5K5-01A-11D-A29J-05	c70685d2-1d32-44f9-9ce6-e44b229e0bb0	TCGA-OR-A5K5-01A-11D-A29I-10	TCGA-OR-A5K5-01	c70685d2-1d32-44f9-9ce6-e44b229e0bb0	c70685d2-1d32-44f9-9ce6-e44b229e0bb0	TCGA-OR-A5K5-01	c70685d2-1d32-44f9-9ce6-e44b229e0bb0	TCGA-OR-A5K5-01A-11D-A29H-01	TCGA-OR-A5K5-01A-11R-A29W-13	TCGA-OR-A5K5-01A-11D-A29I-10
TCGA-OR-A5K6-01	0	TCGA-OR-A5K6-01	1493	0	TCGA-OR-A5K6	391	1	1493	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer	YES	NO	56	Atypical Mitotic Figures Present	TCGA-OR-A5K6-F61830	M0	Normal	Cytoplasm presence <= 25% Present	-20657	946		0	1493	1003	391	Diffuse Architecture Absent		Both Clinical and Biochemical Assessments	Cortisol	2014-7-8	FEMALE	YES	Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	120	Invasion of Tumor Capsule Absent	NO	Left	NO				7	YES	NO	YES	Mitotic Rate > 5/50 HPF Present		Necrosis Present	Pathology	Liver	Distant Metastasis		YES	YES	Nuclear Grade III or IV Present		false	N0	T2	Stage II	TCGA-OR-A5K6.CB9B68D7-762B-4828-9479-4ECFE346AB5C.pdf	0	0	0	0	0	0	100	95	WITH TUMOR	No imaging evidence of disease	YES	NO	Complete Remission/Response	No	NO	R0		Primary Tumor	01	Sinusoid Invasion Absent		YES	YES		YES	NO	OR	Adrenal	A	LIVING	5	Venous Invasion Absent	2010	95e23d17-a163-464b-a166-59835b0a1e28	TCGA-OR-A5K6-01A-11D-A29H-01	TCGA-OR-A5K6-01A-11D-A29I-10	95e23d17-a163-464b-a166-59835b0a1e28	TCGA-OR-A5K6-01A-11D-A29I-10	1A7C62C2-00E2-415E-9C4F-318297C57ECE	TCGA-OR-A5K6-01A-11D-A29I-10	TCGA-OR-A5K6-01A-11D-A29J-05	eeda9161-2cf5-4ae2-b8ca-99bd13c053e4	TCGA-OR-A5K6-01A-11D-A29I-10	TCGA-OR-A5K6-01	eeda9161-2cf5-4ae2-b8ca-99bd13c053e4	eeda9161-2cf5-4ae2-b8ca-99bd13c053e4	TCGA-OR-A5K6-01	eeda9161-2cf5-4ae2-b8ca-99bd13c053e4	TCGA-OR-A5K6-01A-11D-A29H-01	TCGA-OR-A5K6-01A-11R-A29W-13	TCGA-OR-A5K6-01A-11D-A29I-10
TCGA-OR-A5K8-01	0	TCGA-OR-A5K8-01	749	0	TCGA-OR-A5K8	749	0	749	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			39	Atypical Mitotic Figures Absent	TCGA-OR-A5K8-F59328	M0	Normal	Cytoplasm presence <= 25% Absent	-14435	260		0	749			Diffuse Architecture Present		Both Clinical and Biochemical Assessments	Cortisol	2014-5-8	MALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	590	Invasion of Tumor Capsule Present	NO	Right	NO				7	YES	YES	NO	Mitotic Rate > 5/50 HPF Present	NO	Necrosis Absent						NO	Nuclear Grade III or IV Present		true	N0	T2	Stage II	TCGA-OR-A5K8.1C0D3231-1F36-4645-95D2-C6BFF78734C9.pdf	0	0	0	0	0	0	100	97	TUMOR FREE	No imaging evidence of disease	YES	NO	Complete Remission/Response	No	NO	R0		Primary Tumor	01	Sinusoid Invasion Absent	NO				YES	NO	OR	Adrenal	A	LIVING	4	Venous Invasion Absent	2012	365fa3bc-de04-4fe3-bfe4-7564effba492	TCGA-OR-A5K8-01A-11D-A29H-01	TCGA-OR-A5K8-01A-11D-A29I-10	365fa3bc-de04-4fe3-bfe4-7564effba492	TCGA-OR-A5K8-01A-11D-A29I-10	249586F7-DC75-489A-886E-3AECB9FA7B4B	TCGA-OR-A5K8-01A-11D-A29I-10	TCGA-OR-A5K8-01A-11D-A29J-05	53390804-e59b-4e73-aee4-89daa7cde164	TCGA-OR-A5K8-01A-11D-A29I-10	TCGA-OR-A5K8-01	53390804-e59b-4e73-aee4-89daa7cde164	53390804-e59b-4e73-aee4-89daa7cde164	TCGA-OR-A5K8-01	53390804-e59b-4e73-aee4-89daa7cde164	TCGA-OR-A5K8-01A-11D-A29H-01	TCGA-OR-A5K8-01A-11R-A29W-13	TCGA-OR-A5K8-01A-11D-A29I-10
TCGA-OR-A5K9-01	1	TCGA-OR-A5K9-01	344	1	TCGA-OR-A5K9			344	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			61			M0			-22596	3864	344	0						Both Clinical and Biochemical Assessments	Androgen|Cortisol	2013-9-11	FEMALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	130		NO	Right						YES	YES										YES			false	N0	T2	Stage II	TCGA-OR-A5K9.EAC92541-2274-4FB8-B56B-657413EDF0F9.pdf	0	0	0	0	0	0	100	95	WITH TUMOR	No imaging evidence of disease	NO	NO		No	NO	R0		Primary Tumor	01						NO	YES	OR	Adrenal	A	DECEASED			2002	3d18122c-81d2-4112-8250-3d2f04896a63	TCGA-OR-A5K9-01A-11D-A29H-01	TCGA-OR-A5K9-01A-11D-A29I-10	3d18122c-81d2-4112-8250-3d2f04896a63	TCGA-OR-A5K9-01A-11D-A29I-10		TCGA-OR-A5K9-01A-11D-A29I-10	TCGA-OR-A5K9-01A-11D-A29J-05	48dd74fe-11ff-4514-87b3-1569e9606c73	TCGA-OR-A5K9-01A-11D-A29I-10	TCGA-OR-A5K9-01	48dd74fe-11ff-4514-87b3-1569e9606c73	48dd74fe-11ff-4514-87b3-1569e9606c73	TCGA-OR-A5K9-01	48dd74fe-11ff-4514-87b3-1569e9606c73	TCGA-OR-A5K9-01A-11D-A29H-01	TCGA-OR-A5K9-01A-11R-A29W-13	TCGA-OR-A5K9-01A-11D-A29I-10
TCGA-OR-A5KB-01	0	TCGA-OR-A5KB-01	741	0	TCGA-OR-A5KB	214	1	741	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer	YES	NO	61	Atypical Mitotic Figures Present	TCGA-OR-A5KB-F59331	M0	Normal	Cytoplasm presence <= 25% Absent	-22550	355		0	741		214	Diffuse Architecture Present			None	2014-5-8	FEMALE	YES	Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	60	Invasion of Tumor Capsule Present	NO	Left	NO	3			129	YES	YES		Mitotic Rate > 5/50 HPF Present	NO	Necrosis Present	Pathology	Soft Tissue	Distant Metastasis		NO	YES	Nuclear Grade III or IV Present	0	true	N0	T2	Stage II	TCGA-OR-A5KB.7553DC0B-FD8C-42E9-B38F-65EA954C6BC6.pdf	0	0	2	0	0	0	98	88	WITH TUMOR	No imaging evidence of disease	YES	YES	Progressive Disease	No	NO	R0		Primary Tumor	01	Sinusoid Invasion Absent	YES				NO	YES	OR	Adrenal	A	LIVING	7	Venous Invasion Present	2011	f71a8133-9597-4e81-819e-485b523ae635	TCGA-OR-A5KB-01A-11D-A309-01	TCGA-OR-A5KB-01A-11D-A30A-10	f71a8133-9597-4e81-819e-485b523ae635	TCGA-OR-A5KB-01A-11D-A30A-10		TCGA-OR-A5KB-01A-11D-A30A-10			TCGA-OR-A5KB-01A-11D-A30A-10						TCGA-OR-A5KB-01A-11D-A309-01		TCGA-OR-A5KB-01A-11D-A30A-10
TCGA-OR-A5KO-01	0	TCGA-OR-A5KO-01	1414	0	TCGA-OR-A5KO	541	1	1414	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer	YES	NO	39	Atypical Mitotic Figures Present	TCGA-OR-A5KO-F60521	M1	Liver Involvement	Cytoplasm presence <= 25% Present	-14606	1120		0	1414	561	541	Diffuse Architecture Present		Both Clinical and Biochemical Assessments	Cortisol	2014-6-10	FEMALE	YES	Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	80	Invasion of Tumor Capsule Present	NO	Right	NO		Biopsy Proven|Imaging Suspected			YES	YES		Mitotic Rate > 5/50 HPF Present	NO	Necrosis Present	Pathology	Lung	Distant Metastasis		YES	YES	Nuclear Grade III or IV Present		true	N0	T4	Stage IV	TCGA-OR-A5KO.B9C848FD-453C-4A56-B625-C4C680790D6A.pdf	0	0	0	0	0	1	99	99	WITH TUMOR	No imaging evidence of disease	YES		Complete Remission/Response	No	NO	R0		Primary Tumor	01	Sinusoid Invasion Present	NO				NO	YES	OR	Adrenal	A	LIVING	9	Venous Invasion Present	2009	154e9edd-b354-4e62-be0f-8b26ebddffbc	TCGA-OR-A5KO-01A-11D-A29H-01	TCGA-OR-A5KO-01A-11D-A29I-10	154e9edd-b354-4e62-be0f-8b26ebddffbc	TCGA-OR-A5KO-01A-11D-A29I-10	FFAC8C02-F5D7-4291-8A9A-EC07D7B0AAAC	TCGA-OR-A5KO-01A-11D-A29I-10	TCGA-OR-A5KO-01A-11D-A29J-05	0ffc0b01-bc1c-4277-8fc4-865590dcc461	TCGA-OR-A5KO-01A-11D-A29I-10	TCGA-OR-A5KO-01	0ffc0b01-bc1c-4277-8fc4-865590dcc461	0ffc0b01-bc1c-4277-8fc4-865590dcc461	TCGA-OR-A5KO-01	0ffc0b01-bc1c-4277-8fc4-865590dcc461	TCGA-OR-A5KO-01A-11D-A29H-01	TCGA-OR-A5KO-01A-11R-A29W-13	TCGA-OR-A5KO-01A-11D-A29I-10
TCGA-OR-A5KP-01	0	TCGA-OR-A5KP-01	2777	0	TCGA-OR-A5KP	1250	1	2777	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer	NO	NO	45	Atypical Mitotic Figures Absent	TCGA-OR-A5KP-F60584	M0	Normal	Cytoplasm presence <= 25% Present	-16702	2281		0	2777	1267	1250	Diffuse Architecture Present		Both Clinical and Biochemical Assessments	Androgen|Cortisol	2014-6-11	FEMALE	YES	Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	80	Invasion of Tumor Capsule Present	NO	Left	NO	2				YES	YES		Mitotic Rate > 5/50 HPF Absent	NO	Necrosis Present	Pathology	Liver	Distant Metastasis		YES	YES	Nuclear Grade III or IV Absent	0	true	N0	T2	Stage II	TCGA-OR-A5KP.C07E8EA7-A221-40F9-9D19-A59DE0E52200.pdf	5	0	0	0	0	5	95	90	TUMOR FREE	No imaging evidence of disease	YES	YES	Complete Remission/Response	Yes	NO	R0		Primary Tumor	01	Sinusoid Invasion Present	YES				NO	YES	OR	Adrenal	A	LIVING	6	Venous Invasion Present	2006	71b0e121-a5ad-4b9a-8003-417c8fe715f7	TCGA-OR-A5KP-01A-11D-A309-01	TCGA-OR-A5KP-01A-11D-A30A-10	71b0e121-a5ad-4b9a-8003-417c8fe715f7	TCGA-OR-A5KP-01A-11D-A30A-10		TCGA-OR-A5KP-01A-11D-A30A-10			TCGA-OR-A5KP-01A-11D-A30A-10						TCGA-OR-A5KP-01A-11D-A309-01		TCGA-OR-A5KP-01A-11D-A30A-10
TCGA-OR-A5KQ-01	0	TCGA-OR-A5KQ-01	2677	0	TCGA-OR-A5KQ	2677	0	2677	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			20	Atypical Mitotic Figures Absent	TCGA-OR-A5KQ-F60587	M0	Normal	Cytoplasm presence <= 25% Present	-7459	2490		0	2677			Diffuse Architecture Absent		Both Clinical and Biochemical Assessments	Androgen|Mineralocorticoids	2014-6-11	FEMALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	60	Invasion of Tumor Capsule Absent	NO	Right	NO					NO	NO		Mitotic Rate > 5/50 HPF Absent	NO	Necrosis Absent						NO	Nuclear Grade III or IV Present		true	N0	T2	Stage II	TCGA-OR-A5KQ.7ED6314A-1343-47D5-A40D-4B53FA3D33DF.pdf	0	0	0	0	0	5	95	100	TUMOR FREE	No imaging evidence of disease	NO		Complete Remission/Response	No	NO	R0		Primary Tumor	01	Sinusoid Invasion Present					NO	YES	OR	Adrenal	A	LIVING	3	Venous Invasion Absent	2006	e33c7b1d-c1ad-4934-abca-2aa9f9bf0130	TCGA-OR-A5KQ-01A-11D-A309-01	TCGA-OR-A5KQ-01A-11D-A30A-10	e33c7b1d-c1ad-4934-abca-2aa9f9bf0130	TCGA-OR-A5KQ-01A-11D-A30A-10		TCGA-OR-A5KQ-01A-11D-A30A-10			TCGA-OR-A5KQ-01A-11D-A30A-10						TCGA-OR-A5KQ-01A-11D-A309-01		TCGA-OR-A5KQ-01A-11D-A30A-10
TCGA-OR-A5KS-01	0	TCGA-OR-A5KS-01	2549	0	TCGA-OR-A5KS	2549	0	2549	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			72		TCGA-OR-A5KS-F61319	M0	Normal		-26404	2425		0	2549						None	2014-6-26	MALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/1	C74.0	YES	120		NO	Left	NO				0	NO	NO			NO	Necrosis Present						NO			true	N0	T2	Stage II	TCGA-OR-A5KS.CF5CAAE7-CEA0-4505-A33F-7E7588DB7D7C.pdf	0	0	0	0	0	5	95	100	TUMOR FREE	No imaging evidence of disease	NO	NO	Complete Remission/Response	No	NO	R0		Primary Tumor	01						NO	YES	OR	Adrenal	A	LIVING			2006	fcb181fe-de38-4d26-846a-00c718238ecd	TCGA-OR-A5KS-01A-11D-A309-01	TCGA-OR-A5KS-01A-11D-A30A-10	fcb181fe-de38-4d26-846a-00c718238ecd	TCGA-OR-A5KS-01A-11D-A30A-10		TCGA-OR-A5KS-01A-11D-A30A-10			TCGA-OR-A5KS-01A-11D-A30A-10						TCGA-OR-A5KS-01A-11D-A309-01		TCGA-OR-A5KS-01A-11D-A30A-10
TCGA-OR-A5KT-01	0	TCGA-OR-A5KT-01	2895	0	TCGA-OR-A5KT	2099	1	2895	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer	YES	NO	44	Atypical Mitotic Figures Absent	TCGA-OR-A5KT-F60526	M0	Normal	Cytoplasm presence <= 25% Present	-16217	2399		0	2895	2112	2099	Diffuse Architecture Absent		Both Clinical and Biochemical Assessments	Androgen|Cortisol	2014-6-10	FEMALE	YES	Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	80	Invasion of Tumor Capsule Absent	NO	Left	NO				1	NO	NO		Mitotic Rate > 5/50 HPF Absent	NO	Necrosis Present	Pathology	Other, specify	Distant Metastasis	Pancreas	YES	YES	Nuclear Grade III or IV Absent		true	N0	T1	Stage I	TCGA-OR-A5KT.7BE65565-0C63-466C-AE5D-A9B47BB354C9.pdf	0	0	0	0	0	5	95	100	TUMOR FREE	No imaging evidence of disease	NO		Complete Remission/Response	No	NO	R0		Primary Tumor	01	Sinusoid Invasion Absent					NO	YES	OR	Adrenal	A	LIVING	2	Venous Invasion Absent	2006	499cad1d-5d42-4834-8b88-42aec6523e07	TCGA-OR-A5KT-01A-11D-A29H-01	TCGA-OR-A5KT-01A-11D-A29I-10	499cad1d-5d42-4834-8b88-42aec6523e07	TCGA-OR-A5KT-01A-11D-A29I-10		TCGA-OR-A5KT-01A-11D-A29I-10	TCGA-OR-A5KT-01A-11D-A29J-05	8448744c-2c5f-4a95-b517-5652f6bacc1a	TCGA-OR-A5KT-01A-11D-A29I-10	TCGA-OR-A5KT-01	8448744c-2c5f-4a95-b517-5652f6bacc1a	8448744c-2c5f-4a95-b517-5652f6bacc1a	TCGA-OR-A5KT-01	8448744c-2c5f-4a95-b517-5652f6bacc1a	TCGA-OR-A5KT-01A-11D-A29H-01	TCGA-OR-A5KT-01A-11R-A29W-13	TCGA-OR-A5KT-01A-11D-A29I-10
TCGA-OR-A5KU-01	0	TCGA-OR-A5KU-01	4673	0	TCGA-OR-A5KU	4673	0	4673	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			37	Atypical Mitotic Figures Absent	TCGA-OR-A5KU-F60523	M0	Normal	Cytoplasm presence <= 25% Present	-13559	4543		0	4673			Diffuse Architecture Absent		Both Clinical and Biochemical Assessments	Mineralocorticoids	2014-6-10	FEMALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/1	C74.0	YES	70	Invasion of Tumor Capsule Absent	NO	Left	NO	1				YES	YES		Mitotic Rate > 5/50 HPF Absent	NO	Necrosis Present						NO	Nuclear Grade III or IV Absent	0	true	N0	T2	Stage II	TCGA-OR-A5KU.F9F537ED-3066-4E99-B6D1-112D6C4551F0.pdf	0	0	15	0	0	5	80	100	TUMOR FREE	No imaging evidence of disease	YES	YES	Complete Remission/Response	No	NO	R0		Primary Tumor	01	Sinusoid Invasion Absent	NO			NO	NO	YES	OR	Adrenal	A	LIVING	2	Venous Invasion Absent	2000	3a9f554e-420f-422a-b377-9ef347a926cf	TCGA-OR-A5KU-01A-11D-A29H-01	TCGA-OR-A5KU-01A-11D-A29I-10	3a9f554e-420f-422a-b377-9ef347a926cf	TCGA-OR-A5KU-01A-11D-A29I-10	49C334C1-C014-4BDD-817D-5BAF647C130C	TCGA-OR-A5KU-01A-11D-A29I-10	TCGA-OR-A5KU-01A-11D-A29J-05	c2e40ad2-0d7f-4e25-a93a-f9dba30bc838	TCGA-OR-A5KU-01A-11D-A29I-10	TCGA-OR-A5KU-01	c2e40ad2-0d7f-4e25-a93a-f9dba30bc838	c2e40ad2-0d7f-4e25-a93a-f9dba30bc838	TCGA-OR-A5KU-01	c2e40ad2-0d7f-4e25-a93a-f9dba30bc838	TCGA-OR-A5KU-01A-11D-A29H-01	TCGA-OR-A5KU-01A-11R-A29W-13	TCGA-OR-A5KU-01A-11D-A29I-10
TCGA-OR-A5KV-01	0	TCGA-OR-A5KV-01	3878	0	TCGA-OR-A5KV	1116	1	3878	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer	NO	NO	17	Atypical Mitotic Figures Present	TCGA-OR-A5KV-F60525	M0	Retroperitoneal Lymph Node Involvement	Cytoplasm presence <= 25% Absent	-6250	3429		0	3878	1120	1116	Diffuse Architecture Absent		Biochemical Assessment	Androgen|Cortisol	2014-6-10	FEMALE	YES	Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	50	Invasion of Tumor Capsule Absent	NO	Left	NO	1				NO	NO		Mitotic Rate > 5/50 HPF Absent	NO	Necrosis Present	Imaging	Lung	Distant Metastasis		YES	YES	Nuclear Grade III or IV Present	1	true	N1	T2	Stage III	TCGA-OR-A5KV.D85CC5BA-0A85-4BCB-8088-9EBA37211501.pdf	0	0	0	0	0	4	96	100	TUMOR FREE	No imaging evidence of disease	NO	YES	Complete Remission/Response	No	YES	R0		Primary Tumor	01	Sinusoid Invasion Absent					NO	YES	OR	Adrenal	A	LIVING	3	Venous Invasion Absent	2003	0298819c-c447-44f3-9067-433801c5838a	TCGA-OR-A5KV-01A-11D-A29H-01	TCGA-OR-A5KV-01A-11D-A29I-10	0298819c-c447-44f3-9067-433801c5838a	TCGA-OR-A5KV-01A-11D-A29I-10		TCGA-OR-A5KV-01A-11D-A29I-10	TCGA-OR-A5KV-01A-11D-A29J-05	512b54a3-49c4-4dbd-b853-290500c00e81	TCGA-OR-A5KV-01A-11D-A29I-10	TCGA-OR-A5KV-01	512b54a3-49c4-4dbd-b853-290500c00e81	512b54a3-49c4-4dbd-b853-290500c00e81	TCGA-OR-A5KV-01	512b54a3-49c4-4dbd-b853-290500c00e81	TCGA-OR-A5KV-01A-11D-A29H-01	TCGA-OR-A5KV-01A-11R-A29W-13	TCGA-OR-A5KV-01A-11D-A29I-10
TCGA-OR-A5KW-01	0	TCGA-OR-A5KW-01	1532	0	TCGA-OR-A5KW	1532	0	1532	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			55		TCGA-OR-A5KW-F60532	M0	Retroperitoneal Lymph Node Involvement		-20328	1245		0	1532					Both Clinical and Biochemical Assessments	Androgen|Cortisol	2014-6-10	FEMALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	230		NO	Right	NO	9			10	YES	YES			NO							NO		8	true	N1	T2	Stage III	TCGA-OR-A5KW.751F5B53-9186-4602-B824-8593E63EAC3F.pdf	0	0	0	0	0	5	95	100	TUMOR FREE	No imaging evidence of disease	YES	YES	Complete Remission/Response	No	YES	R0		Primary Tumor	01		YES			NO	NO	YES	OR	Adrenal	A	LIVING			2009	c49aaf3f-7f87-42fc-b5a9-ddb5661464e3	TCGA-OR-A5KW-01A-11D-A29H-01	TCGA-OR-A5KW-01A-11D-A29I-10	c49aaf3f-7f87-42fc-b5a9-ddb5661464e3	TCGA-OR-A5KW-01A-11D-A29I-10	767EAE99-8013-4CC9-ACA6-DCA18CD8A8D0	TCGA-OR-A5KW-01A-11D-A29I-10	TCGA-OR-A5KW-01A-11D-A29J-05	64934de4-399f-4fbc-b283-979ab40addbc	TCGA-OR-A5KW-01A-11D-A29I-10	TCGA-OR-A5KW-01	64934de4-399f-4fbc-b283-979ab40addbc	64934de4-399f-4fbc-b283-979ab40addbc	TCGA-OR-A5KW-01	64934de4-399f-4fbc-b283-979ab40addbc	TCGA-OR-A5KW-01A-11D-A29H-01	TCGA-OR-A5KW-01A-11R-A29W-13	TCGA-OR-A5KW-01A-11D-A29I-10
TCGA-OR-A5KX-01	0	TCGA-OR-A5KX-01	1364	0	TCGA-OR-A5KX	62	1	1364	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer	YES	YES	25	Atypical Mitotic Figures Absent	TCGA-OR-A5KX-F60522	M0	Normal	Cytoplasm presence <= 25% Present	-9298	914		0	1364	69	62	Diffuse Architecture Present				2014-6-10	FEMALE	YES	Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	190	Invasion of Tumor Capsule Present	NO	Left	NO					YES	YES		Mitotic Rate > 5/50 HPF Present	NO	Necrosis Present	Pathology	Bone	Distant Metastasis		YES	YES	Nuclear Grade III or IV Present		true	N1	T2	Stage III	TCGA-OR-A5KX.02EBE0C2-AE20-4F08-81E7-3EC45E12C0F4.pdf	1	0	1	0	0	0	99	80	WITH TUMOR	Persistent distant metastases	YES	YES	Progressive Disease	No	NO	R0		Primary Tumor	01	Sinusoid Invasion Absent	YES				NO	YES	OR	Adrenal	A	LIVING	7	Venous Invasion Present	2010	1acc357d-6f1e-4f1f-a752-777196037a59	TCGA-OR-A5KX-01A-11D-A29H-01	TCGA-OR-A5KX-01A-11D-A29I-10	1acc357d-6f1e-4f1f-a752-777196037a59	TCGA-OR-A5KX-01A-11D-A29I-10	C9B17637-359A-485E-9CA4-0E92B840CD03	TCGA-OR-A5KX-01A-11D-A29I-10	TCGA-OR-A5KX-01A-11D-A29J-05	180a84c1-99c0-4014-b42e-8e01f88980aa	TCGA-OR-A5KX-01A-11D-A29I-10	TCGA-OR-A5KX-01	180a84c1-99c0-4014-b42e-8e01f88980aa	180a84c1-99c0-4014-b42e-8e01f88980aa	TCGA-OR-A5KX-01	180a84c1-99c0-4014-b42e-8e01f88980aa	TCGA-OR-A5KX-01A-11D-A29H-01	TCGA-OR-A5KX-01A-11R-A29W-13	TCGA-OR-A5KX-01A-11D-A29I-10
TCGA-OR-A5KY-01	1	TCGA-OR-A5KY-01	391	1	TCGA-OR-A5KY			391	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			23	Atypical Mitotic Figures Present		M1	Lung Involvement	Cytoplasm presence <= 25% Present	-8745	939	391	0				Diffuse Architecture Absent		Both Clinical and Biochemical Assessments	Androgen|Cortisol	2013-11-5	FEMALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	120	Invasion of Tumor Capsule Present	NO	Left		52	Imaging Suspected		5	YES	NO	YES	Mitotic Rate > 5/50 HPF Absent	NO	Necrosis Absent						YES	Nuclear Grade III or IV Absent	52	true	N1	T4	Stage IV	TCGA-OR-A5KY.23328F06-11F8-4D12-BA95-D5CC9AEFE22A.pdf	1	0	0	0	0	0	100	80	WITH TUMOR	Persistent distant metastases	YES	YES	Progressive Disease	No	NO	R2		Primary Tumor	01	Sinusoid Invasion Absent		YES	NO		NO	YES	OR	Adrenal	A	DECEASED	3	Venous Invasion Absent	2010	ce287f91-80f7-4187-ae42-c85b4d67ff07	TCGA-OR-A5KY-01A-11D-A29H-01	TCGA-OR-A5KY-01A-11D-A29I-10	ce287f91-80f7-4187-ae42-c85b4d67ff07	TCGA-OR-A5KY-01A-11D-A29I-10	75604E70-38A0-424C-97A9-4A1BA8F854CC	TCGA-OR-A5KY-01A-11D-A29I-10	TCGA-OR-A5KY-01A-11D-A29J-05	bf4dc301-6b99-46c3-bdc4-d85905688e05	TCGA-OR-A5KY-01A-11D-A29I-10	TCGA-OR-A5KY-01	bf4dc301-6b99-46c3-bdc4-d85905688e05	bf4dc301-6b99-46c3-bdc4-d85905688e05	TCGA-OR-A5KY-01	bf4dc301-6b99-46c3-bdc4-d85905688e05	TCGA-OR-A5KY-01A-11D-A29H-01	TCGA-OR-A5KY-01A-11R-A29W-13	TCGA-OR-A5KY-01A-11D-A29I-10
TCGA-OR-A5KZ-01	1	TCGA-OR-A5KZ-01	125	1	TCGA-OR-A5KZ			125	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			42	Atypical Mitotic Figures Absent		M0	Normal	Cytoplasm presence <= 25% Present	-15594	319	125	0				Diffuse Architecture Present		Both Clinical and Biochemical Assessments	Cortisol	2013-11-7	MALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	120	Invasion of Tumor Capsule Present	NO	Left						YES	YES		Mitotic Rate > 5/50 HPF Present	NO	Necrosis Present						YES	Nuclear Grade III or IV Present		true	N0	T2	Stage II	TCGA-OR-A5KZ.22298C81-A72D-4E22-99DD-6541FB0953A4.pdf	1	0	19	0	0	0	81	80	WITH TUMOR	Persistent locoregional disease	YES		Progressive Disease	No	NO	RX		Primary Tumor	01	Sinusoid Invasion Present					NO	YES	OR	Adrenal	A	DECEASED	8	Venous Invasion Present	2012	b297985e-db11-4529-a32b-28b9b34c4173	TCGA-OR-A5KZ-01A-11D-A29H-01	TCGA-OR-A5KZ-01A-11D-A29I-10	b297985e-db11-4529-a32b-28b9b34c4173	TCGA-OR-A5KZ-01A-11D-A29I-10	5D348448-A293-4A3F-81F2-94BDD97B882D	TCGA-OR-A5KZ-01A-11D-A29I-10	TCGA-OR-A5KZ-01A-11D-A29J-05	6991a561-ff49-4546-9bc7-74cca88916ae	TCGA-OR-A5KZ-01A-11D-A29I-10	TCGA-OR-A5KZ-01	6991a561-ff49-4546-9bc7-74cca88916ae	6991a561-ff49-4546-9bc7-74cca88916ae	TCGA-OR-A5KZ-01	6991a561-ff49-4546-9bc7-74cca88916ae	TCGA-OR-A5KZ-01A-11D-A29H-01	TCGA-OR-A5KZ-01A-11R-A29W-13	TCGA-OR-A5KZ-01A-11D-A29I-10
TCGA-OR-A5L1-01	0	TCGA-OR-A5L1-01	1781	0	TCGA-OR-A5L1			1781	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			37			M0	Normal		-13840	4424		0	1781					Biochemical Assessment	Cortisol	2014-6-27	FEMALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	160		NO	Left						YES	YES			NO	Necrosis Present						YES			true	N0	T2	Stage II	TCGA-OR-A5L1.914A8783-5ACF-4580-A663-E73BDDAA7286.pdf	0	0	0	0	0	20	80	90	WITH TUMOR		YES	NO	Complete Remission/Response	No	NO	R0		Primary Tumor	01						NO	YES	OR	Adrenal	A	LIVING			2000	4d4289e3-09ce-432e-b412-afaba4cd1b94	TCGA-OR-A5L1-01A-11D-A309-01	TCGA-OR-A5L1-01A-11D-A30A-10	4d4289e3-09ce-432e-b412-afaba4cd1b94	TCGA-OR-A5L1-01A-11D-A30A-10		TCGA-OR-A5L1-01A-11D-A30A-10			TCGA-OR-A5L1-01A-11D-A30A-10						TCGA-OR-A5L1-01A-11D-A309-01		TCGA-OR-A5L1-01A-11D-A30A-10
TCGA-OR-A5L2-01	1	TCGA-OR-A5L2-01	1852	1	TCGA-OR-A5L2	1852	0	1852	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			83	Atypical Mitotic Figures Present	TCGA-OR-A5L2-F61320	M0	Normal		-30535	4313	1852	0								2014-6-26	FEMALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/1	C74.0	YES	110	Invasion of Tumor Capsule Absent	NO	Left	NO				30	NO	NO		Mitotic Rate > 5/50 HPF Present	NO	Necrosis Present						NO			true	N0	T2	Stage II	TCGA-OR-A5L2.A3E8E475-D5A7-4A4C-AA1D-3B3AE50F572B.pdf	0	0	0	0	0	20	80	90	TUMOR FREE	No imaging evidence of disease	NO	NO	Complete Remission/Response	No	NO	R0		Primary Tumor	01						NO	YES	OR	Adrenal	A	DECEASED			2001	49d3c8a0-667e-4599-b8eb-1cd0e3449062	TCGA-OR-A5L2-01A-11D-A309-01	TCGA-OR-A5L2-01A-11D-A30A-10	49d3c8a0-667e-4599-b8eb-1cd0e3449062	TCGA-OR-A5L2-01A-11D-A30A-10		TCGA-OR-A5L2-01A-11D-A30A-10			TCGA-OR-A5L2-01A-11D-A30A-10						TCGA-OR-A5L2-01A-11D-A309-01		TCGA-OR-A5L2-01A-11D-A30A-10
TCGA-OR-A5L3-01	0	TCGA-OR-A5L3-01	4628	0	TCGA-OR-A5L3	4628	0	4628	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			67	Atypical Mitotic Figures Absent	TCGA-OR-A5L3-F60524	M0	Normal	Cytoplasm presence <= 25% Absent	-24763	4591		0	4628			Diffuse Architecture Absent		Both Clinical and Biochemical Assessments	Cortisol	2014-6-10	FEMALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	70	Invasion of Tumor Capsule Absent	NO	Right	NO					NO	NO		Mitotic Rate > 5/50 HPF Absent	NO	Necrosis Present						NO	Nuclear Grade III or IV Present		true	N0	T1	Stage I	TCGA-OR-A5L3.FE1CF238-753C-4DF4-A083-74DDC753DF45.pdf	0	0	0	0	0	15	85	90	TUMOR FREE	No imaging evidence of disease	NO		Complete Remission/Response	No	NO	R0		Primary Tumor	01	Sinusoid Invasion Present					NO	YES	OR	Adrenal	A	LIVING	3	Venous Invasion Absent	2000	3f30b69f-77aa-4ece-850a-75060bdc60ec	TCGA-OR-A5L3-01A-11D-A29H-01	TCGA-OR-A5L3-01A-11D-A29I-10	3f30b69f-77aa-4ece-850a-75060bdc60ec	TCGA-OR-A5L3-01A-11D-A29I-10		TCGA-OR-A5L3-01A-11D-A29I-10	TCGA-OR-A5L3-01A-11D-A29J-05	20f7acf8-7813-4ec8-af92-19f92d875a58	TCGA-OR-A5L3-01A-11D-A29I-10	TCGA-OR-A5L3-01	20f7acf8-7813-4ec8-af92-19f92d875a58	20f7acf8-7813-4ec8-af92-19f92d875a58	TCGA-OR-A5L3-01	20f7acf8-7813-4ec8-af92-19f92d875a58	TCGA-OR-A5L3-01A-11D-A29H-01	TCGA-OR-A5L3-01A-11R-A29W-13	TCGA-OR-A5L3-01A-11D-A29I-10
TCGA-OR-A5L4-01	0	TCGA-OR-A5L4-01	967	0	TCGA-OR-A5L4	967	0	967	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			48	Atypical Mitotic Figures Absent	TCGA-OR-A5L4-F60529	M0	Normal	Cytoplasm presence <= 25% Present	-17819	456		0	967			Diffuse Architecture Present		Both Clinical and Biochemical Assessments	Androgen|Cortisol	2014-6-10	FEMALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	80	Invasion of Tumor Capsule Present	NO	Right	NO					YES	YES		Mitotic Rate > 5/50 HPF Absent	NO	Necrosis Present						NO	Nuclear Grade III or IV Present		true	N0	T4	Stage III	TCGA-OR-A5L4.B140F5B4-5B03-40EC-A5BB-BCF0963EC567.pdf	0	0	5	0	0	5	90	95	TUMOR FREE	No imaging evidence of disease	YES		Complete Remission/Response	No	NO	RX		Primary Tumor	01	Sinusoid Invasion Present	YES			NO	NO	YES	OR	Adrenal	A	LIVING	7	Venous Invasion Present	2011	4c1c12d0-aad4-47cb-b27a-d3426d4e44a7	TCGA-OR-A5L4-01A-11D-A29H-01	TCGA-OR-A5L4-01A-11D-A29I-10	4c1c12d0-aad4-47cb-b27a-d3426d4e44a7	TCGA-OR-A5L4-01A-11D-A29I-10		TCGA-OR-A5L4-01A-11D-A29I-10	TCGA-OR-A5L4-01A-11D-A29J-05	67affce9-7c50-46c9-9f1c-f80c1dd9c888	TCGA-OR-A5L4-01A-11D-A29I-10	TCGA-OR-A5L4-01	67affce9-7c50-46c9-9f1c-f80c1dd9c888	67affce9-7c50-46c9-9f1c-f80c1dd9c888	TCGA-OR-A5L4-01	67affce9-7c50-46c9-9f1c-f80c1dd9c888	TCGA-OR-A5L4-01A-11D-A29H-01	TCGA-OR-A5L4-01A-11R-A29W-13	TCGA-OR-A5L4-01A-11D-A29I-10
TCGA-OR-A5L5-01	0	TCGA-OR-A5L5-01	1317	0	TCGA-OR-A5L5	1317	0	1317	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			77	Atypical Mitotic Figures Absent	TCGA-OR-A5L5-F60530	M0	Normal	Cytoplasm presence <= 25% Absent	-28270	828		0	1317			Diffuse Architecture Absent		Biochemical Assessment	Androgen|Estrogen	2014-6-10	FEMALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	70	Invasion of Tumor Capsule Present	NO	Left	NO				15	NO	NO		Mitotic Rate > 5/50 HPF Present	NO	Necrosis Present						NO	Nuclear Grade III or IV Present		true	N0	T1	Stage I	TCGA-OR-A5L5.A1989B2E-FB1F-420A-BF11-2C79F3E81884.pdf	0	0	5	0	0	5	90	95	TUMOR FREE	No imaging evidence of disease	YES	NO	Complete Remission/Response	Yes	NO	R0		Primary Tumor	01						NO	YES	OR	Adrenal	A	LIVING	4		2010	71b91dbf-063c-4b0e-ac12-c56f8812222b	TCGA-OR-A5L5-01A-11D-A29H-01	TCGA-OR-A5L5-01A-11D-A29I-10	71b91dbf-063c-4b0e-ac12-c56f8812222b	TCGA-OR-A5L5-01A-11D-A29I-10		TCGA-OR-A5L5-01A-11D-A29I-10	TCGA-OR-A5L5-01A-11D-A29J-05	2928fe95-b646-44a3-808a-36f0751c887b	TCGA-OR-A5L5-01A-11D-A29I-10	TCGA-OR-A5L5-01	2928fe95-b646-44a3-808a-36f0751c887b	2928fe95-b646-44a3-808a-36f0751c887b	TCGA-OR-A5L5-01	2928fe95-b646-44a3-808a-36f0751c887b	TCGA-OR-A5L5-01A-11D-A29H-01	TCGA-OR-A5L5-01A-11R-A29W-13	TCGA-OR-A5L5-01A-11D-A29I-10
TCGA-OR-A5L6-01	0	TCGA-OR-A5L6-01	861	0	TCGA-OR-A5L6	861	0	861	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			60	Atypical Mitotic Figures Absent	TCGA-OR-A5L6-F60528	M0	Normal	Cytoplasm presence <= 25% Present	-22057	433		0	861			Diffuse Architecture Present		Biochemical Assessment	Androgen	2014-6-10	MALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	80	Invasion of Tumor Capsule Absent	NO	Left	NO				23	NO	NO		Mitotic Rate > 5/50 HPF Present	NO	Necrosis Present						NO	Nuclear Grade III or IV Present		true	N0	T2	Stage II	TCGA-OR-A5L6.6104CA0C-86CD-46C9-A111-0024A75FB727.pdf	0	0	5	0	0	5	90	95	TUMOR FREE	No imaging evidence of disease	NO		Complete Remission/Response	No	NO	R0		Primary Tumor	01	Sinusoid Invasion Present					NO	YES	OR	Adrenal	A	LIVING	7	Venous Invasion Present	2011	6f31f549-75a3-4c9d-a677-e294e868e4c3	TCGA-OR-A5L6-01A-11D-A29H-01	TCGA-OR-A5L6-01A-11D-A29I-10	6f31f549-75a3-4c9d-a677-e294e868e4c3	TCGA-OR-A5L6-01A-11D-A29I-10		TCGA-OR-A5L6-01A-11D-A29I-10	TCGA-OR-A5L6-01A-11D-A29J-05	68206c96-7d72-43e9-92c8-75f6b5a3f14c	TCGA-OR-A5L6-01A-11D-A29I-10	TCGA-OR-A5L6-01	68206c96-7d72-43e9-92c8-75f6b5a3f14c	68206c96-7d72-43e9-92c8-75f6b5a3f14c	TCGA-OR-A5L6-01	68206c96-7d72-43e9-92c8-75f6b5a3f14c	TCGA-OR-A5L6-01A-11D-A29H-01	TCGA-OR-A5L6-01A-11R-A29W-13	TCGA-OR-A5L6-01A-11D-A29I-10
TCGA-OR-A5L8-01	0	TCGA-OR-A5L8-01	885	0	TCGA-OR-A5L8	885	0	885	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			36	Atypical Mitotic Figures Absent	TCGA-OR-A5L8-F60527	M0	Normal	Cytoplasm presence <= 25% Present	-13472	558		0	885			Diffuse Architecture Absent		Both Clinical and Biochemical Assessments	Mineralocorticoids|Cortisol	2014-6-10	FEMALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	70	Invasion of Tumor Capsule Present	NO	Right	NO					YES	YES		Mitotic Rate > 5/50 HPF Absent	NO	Necrosis Absent						NO	Nuclear Grade III or IV Absent		true	N0	T2	Stage II	TCGA-OR-A5L8.C4BBFD0B-83D0-47C8-9662-13691FE6D820.pdf	40	20	5	20	0	5	90	90	TUMOR FREE	No imaging evidence of disease	YES	NO	Complete Remission/Response	No	NO	R0		Primary Tumor	01	Sinusoid Invasion Present	YES			NO	NO	YES	OR	Adrenal	A	LIVING	4	Venous Invasion Present	2011	eb2d3b3f-7cf2-44b8-a071-a9590f32e0fa	TCGA-OR-A5L8-01A-11D-A29H-01	TCGA-OR-A5L8-01A-11D-A29I-10	eb2d3b3f-7cf2-44b8-a071-a9590f32e0fa	TCGA-OR-A5L8-01A-11D-A29I-10		TCGA-OR-A5L8-01A-11D-A29I-10	TCGA-OR-A5L8-01A-11D-A29J-05	3fd3dae2-aeeb-4d42-abcd-7ff49079e909	TCGA-OR-A5L8-01A-11D-A29I-10	TCGA-OR-A5L8-01	3fd3dae2-aeeb-4d42-abcd-7ff49079e909	3fd3dae2-aeeb-4d42-abcd-7ff49079e909	TCGA-OR-A5L8-01	3fd3dae2-aeeb-4d42-abcd-7ff49079e909	TCGA-OR-A5L8-01A-11D-A29H-01	TCGA-OR-A5L8-01A-11R-A29W-13	TCGA-OR-A5L8-01A-11D-A29I-10
TCGA-OR-A5L9-01	0	TCGA-OR-A5L9-01	871	0	TCGA-OR-A5L9	871	0	871	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			53	Atypical Mitotic Figures Absent	TCGA-OR-A5L9-F61321	M0	Normal	Cytoplasm presence <= 25% Present	-19526	457		0	871			Diffuse Architecture Absent		Both Clinical and Biochemical Assessments	Androgen	2014-6-26	FEMALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/1	C74.0	YES	10	Invasion of Tumor Capsule Absent	NO	Right	NO	5			5	YES	YES		Mitotic Rate > 5/50 HPF Absent	NO	Necrosis Present						NO	Nuclear Grade III or IV Present	0	true	N0	T2	Stage II	TCGA-OR-A5L9.09FD99AA-10FF-4E45-9B21-2B3F7D846758.pdf	1	0	0	0	0	0	100	80	TUMOR FREE	No imaging evidence of disease	YES	YES	Complete Remission/Response	No	NO	R0		Primary Tumor	01	Sinusoid Invasion Absent	YES			NO	NO	YES	OR	Adrenal	A	LIVING	3	Venous Invasion Absent	2011	50ab5e94-748b-41f3-a8b8-4fa8e4512a67	TCGA-OR-A5L9-01A-11D-A29H-01	TCGA-OR-A5L9-01A-11D-A29I-10	50ab5e94-748b-41f3-a8b8-4fa8e4512a67	TCGA-OR-A5L9-01A-11D-A29I-10		TCGA-OR-A5L9-01A-11D-A29I-10	TCGA-OR-A5L9-01A-11D-A29J-05	cfa39c30-f619-4cf8-8460-31d5e5a3b3ba	TCGA-OR-A5L9-01A-11D-A29I-10	TCGA-OR-A5L9-01	cfa39c30-f619-4cf8-8460-31d5e5a3b3ba	cfa39c30-f619-4cf8-8460-31d5e5a3b3ba	TCGA-OR-A5L9-01	cfa39c30-f619-4cf8-8460-31d5e5a3b3ba	TCGA-OR-A5L9-01A-11D-A29H-01	TCGA-OR-A5L9-01A-11R-A29W-13	TCGA-OR-A5L9-01A-11D-A29I-10
TCGA-OR-A5LA-01	0	TCGA-OR-A5LA-01	719	0	TCGA-OR-A5LA	719	0	719	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			52	Atypical Mitotic Figures Absent	TCGA-OR-A5LA-F60533	M0	Normal	Cytoplasm presence <= 25% Present	-19242	208		0	719			Diffuse Architecture Present			None	2014-6-10	FEMALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	60	Invasion of Tumor Capsule Present	NO	Left	NO				1	YES	YES		Mitotic Rate > 5/50 HPF Absent	NO	Necrosis Present						NO	Nuclear Grade III or IV Present		true	N0	T2	Stage II	TCGA-OR-A5LA.68F5B84D-8967-4A77-B5D9-65526AB9FFBB.pdf	40	20	10	20	0	0	90	90	TUMOR FREE	No imaging evidence of disease	YES	NO	Complete Remission/Response	No	NO	R0		Primary Tumor	01	Sinusoid Invasion Absent	YES			NO	NO	YES	OR	Adrenal	A	LIVING	5	Venous Invasion Absent	2012	02c9e3f9-7b0a-4921-8a02-9b340bfe4b37	TCGA-OR-A5LA-01A-11D-A29H-01	TCGA-OR-A5LA-01A-11D-A29I-10	02c9e3f9-7b0a-4921-8a02-9b340bfe4b37	TCGA-OR-A5LA-01A-11D-A29I-10		TCGA-OR-A5LA-01A-11D-A29I-10	TCGA-OR-A5LA-01A-11D-A29J-05	8e63ada3-97ca-46ab-984d-6a71a4e4e440	TCGA-OR-A5LA-01A-11D-A29I-10	TCGA-OR-A5LA-01	8e63ada3-97ca-46ab-984d-6a71a4e4e440	8e63ada3-97ca-46ab-984d-6a71a4e4e440	TCGA-OR-A5LA-01	8e63ada3-97ca-46ab-984d-6a71a4e4e440	TCGA-OR-A5LA-01A-11D-A29H-01	TCGA-OR-A5LA-01A-11R-A29W-13	TCGA-OR-A5LA-01A-11D-A29I-10
TCGA-OR-A5LB-01	1	TCGA-OR-A5LB-01	1204	1	TCGA-OR-A5LB			1204	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			59	Atypical Mitotic Figures Absent		M1	Lung Involvement	Cytoplasm presence <= 25% Absent	-21565	2386	1204	0				Diffuse Architecture Present	Vena cava and left atrium of the heart	Biochemical Assessment	Androgen	2013-11-4	MALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	40	Invasion of Tumor Capsule Absent	NO	Right			Other, specify	Operation	8	YES		YES	Mitotic Rate > 5/50 HPF Present	NO	Necrosis Absent						YES	Nuclear Grade III or IV Absent		true	N0	T4	Stage IV	TCGA-OR-A5LB.09038444-9BE4-443C-8FEC-07903972F305.pdf	40	20	10	20	0	0	90	90	WITH TUMOR	No imaging evidence of disease	YES	NO	Progressive Disease	Yes	YES	R0		Primary Tumor	01	Sinusoid Invasion Present		YES	YES		NO	YES	OR	Adrenal	A	DECEASED	4	Venous Invasion Present	2006	a796c599-8450-419f-8a93-b62db685bc07	TCGA-OR-A5LB-01A-11D-A29H-01	TCGA-OR-A5LB-01A-11D-A29I-10	a796c599-8450-419f-8a93-b62db685bc07	TCGA-OR-A5LB-01A-11D-A29I-10		TCGA-OR-A5LB-01A-11D-A29I-10	TCGA-OR-A5LB-01A-11D-A29J-05	881f6b71-7088-42c8-bfec-c86943715b56	TCGA-OR-A5LB-01A-11D-A29I-10	TCGA-OR-A5LB-01	881f6b71-7088-42c8-bfec-c86943715b56	881f6b71-7088-42c8-bfec-c86943715b56	TCGA-OR-A5LB-01	881f6b71-7088-42c8-bfec-c86943715b56	TCGA-OR-A5LB-01A-11D-A29H-01	TCGA-OR-A5LB-01A-11R-A29W-13	TCGA-OR-A5LB-01A-11D-A29I-10
TCGA-OR-A5LC-01	1	TCGA-OR-A5LC-01	159	1	TCGA-OR-A5LC			159	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			71	Atypical Mitotic Figures Absent		M1	Liver Involvement	Cytoplasm presence <= 25% Absent	-26084		159	0				Diffuse Architecture Absent		Both Clinical and Biochemical Assessments	Cortisol	2013-11-4	FEMALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES		Invasion of Tumor Capsule Present		Left			Biopsy Proven|Imaging Suspected			YES		YES	Mitotic Rate > 5/50 HPF Absent	NO	Necrosis Present						YES	Nuclear Grade III or IV Absent			N0	T4	Stage IV										WITH TUMOR	Persistent distant metastases	YES		Progressive Disease	No	NO	R2		Primary Tumor	01	Sinusoid Invasion Absent		NO			NO	YES	OR	Adrenal		DECEASED	3	Venous Invasion Present	2011	f716c644-db79-4cba-8d8b-f54e6af86e45	TCGA-OR-A5LC-01A-11D-A29H-01	TCGA-OR-A5LC-01A-11D-A29I-10	f716c644-db79-4cba-8d8b-f54e6af86e45	TCGA-OR-A5LC-01A-11D-A29I-10		TCGA-OR-A5LC-01A-11D-A29I-10	TCGA-OR-A5LC-01A-11D-A29J-05	cbe8e9e4-f555-47ce-9905-d9f95637c18a	TCGA-OR-A5LC-01A-11D-A29I-10	TCGA-OR-A5LC-01	cbe8e9e4-f555-47ce-9905-d9f95637c18a	cbe8e9e4-f555-47ce-9905-d9f95637c18a	TCGA-OR-A5LC-01	cbe8e9e4-f555-47ce-9905-d9f95637c18a	TCGA-OR-A5LC-01A-11D-A29H-01	TCGA-OR-A5LC-01A-11R-A29W-13	TCGA-OR-A5LC-01A-11D-A29I-10
TCGA-OR-A5LD-01	1	TCGA-OR-A5LD-01	1197	1	TCGA-OR-A5LD			1197	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			52	Atypical Mitotic Figures Absent		M0	Normal	Cytoplasm presence <= 25% Present	-19111	5280	1197	0				Diffuse Architecture Present			None	2013-11-7	MALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	200	Invasion of Tumor Capsule Absent	NO	Left						NO			Mitotic Rate > 5/50 HPF Present	NO	Necrosis Present						YES	Nuclear Grade III or IV Absent		true	N0	T4	Stage III	TCGA-OR-A5LD.08D3F046-01AD-40B2-A4EC-1121366614CA.pdf	40	20	10	20	0	0	90	90	WITH TUMOR	No imaging evidence of disease	NO	NO		No	NO	RX		Primary Tumor	01	Sinusoid Invasion Present					NO	YES	OR	Adrenal	A	DECEASED	5	Venous Invasion Absent	1998	ab185b04-9b48-4c41-989e-1b2e4590ee5a	TCGA-OR-A5LD-01A-11D-A29H-01	TCGA-OR-A5LD-01A-11D-A29I-10	ab185b04-9b48-4c41-989e-1b2e4590ee5a	TCGA-OR-A5LD-01A-11D-A29I-10	0AC0BCF3-1EC0-4DBB-A86D-3953B2F28AE8	TCGA-OR-A5LD-01A-11D-A29I-10	TCGA-OR-A5LD-01A-11D-A29J-05	efd6520f-20a3-416b-87ce-6a1da0da448d	TCGA-OR-A5LD-01A-11D-A29I-10	TCGA-OR-A5LD-01	efd6520f-20a3-416b-87ce-6a1da0da448d	efd6520f-20a3-416b-87ce-6a1da0da448d	TCGA-OR-A5LD-01	efd6520f-20a3-416b-87ce-6a1da0da448d	TCGA-OR-A5LD-01A-11D-A29H-01	TCGA-OR-A5LD-01A-11R-A29W-13	TCGA-OR-A5LD-01A-11D-A29I-10
TCGA-OR-A5LE-01	1	TCGA-OR-A5LE-01	662	1	TCGA-OR-A5LE			662	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			14	Atypical Mitotic Figures Absent		M0	Normal	Cytoplasm presence <= 25% Present	-5383		662	0				Diffuse Architecture Absent				2013-11-4	MALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES		Invasion of Tumor Capsule Absent		Left						NO			Mitotic Rate > 5/50 HPF Present	NO	Necrosis Present						YES	Nuclear Grade III or IV Present			N0	T2	Stage II										WITH TUMOR	No imaging evidence of disease	NO	YES		No	NO	R0		Primary Tumor	01	Sinusoid Invasion Present					NO	YES	OR	Adrenal		DECEASED	5	Venous Invasion Absent	1997	f3e0595b-e839-4c34-b467-56b303181376	TCGA-OR-A5LE-01A-11D-A29H-01	TCGA-OR-A5LE-01A-11D-A29I-10	f3e0595b-e839-4c34-b467-56b303181376	TCGA-OR-A5LE-01A-11D-A29I-10		TCGA-OR-A5LE-01A-11D-A29I-10	TCGA-OR-A5LE-01A-11D-A29J-05	d5597a19-f3ff-431b-85ba-d2f306fe2fab	TCGA-OR-A5LE-01A-11D-A29I-10	TCGA-OR-A5LE-01	d5597a19-f3ff-431b-85ba-d2f306fe2fab	d5597a19-f3ff-431b-85ba-d2f306fe2fab	TCGA-OR-A5LE-01	d5597a19-f3ff-431b-85ba-d2f306fe2fab	TCGA-OR-A5LE-01A-11D-A29H-01	TCGA-OR-A5LE-01A-11R-A29W-13	TCGA-OR-A5LE-01A-11D-A29I-10
TCGA-OR-A5LF-01	1	TCGA-OR-A5LF-01	445	1	TCGA-OR-A5LF	445	0	445	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			74	Atypical Mitotic Figures Absent		M0	Normal	Cytoplasm presence <= 25% Present	-27179	3880	445	0				Diffuse Architecture Present			None	2014-6-27	FEMALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	110	Invasion of Tumor Capsule Present	NO	Left						NO			Mitotic Rate > 5/50 HPF Present	NO	Necrosis Absent						NO	Nuclear Grade III or IV Absent		true	N0	T3	Stage III	TCGA-OR-A5LF.1E988E48-9FF4-4355-89CE-410CC1964D6C.pdf	40	20	10	20	0	0	90	90	TUMOR FREE	No imaging evidence of disease	NO	NO	Complete Remission/Response	No	NO	R0		Primary Tumor	01	Sinusoid Invasion Absent					NO	YES	OR	Adrenal	A	DECEASED	5	Venous Invasion Present	2002	67eb3b89-3122-4d46-8987-ef91c6ba1e0f	TCGA-OR-A5LF-01A-11D-A309-01	TCGA-OR-A5LF-01A-11D-A30A-10	67eb3b89-3122-4d46-8987-ef91c6ba1e0f	TCGA-OR-A5LF-01A-11D-A30A-10		TCGA-OR-A5LF-01A-11D-A30A-10			TCGA-OR-A5LF-01A-11D-A30A-10						TCGA-OR-A5LF-01A-11D-A309-01		TCGA-OR-A5LF-01A-11D-A30A-10
TCGA-OR-A5LG-01	0	TCGA-OR-A5LG-01	1589	0	TCGA-OR-A5LG			1589	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			46	Atypical Mitotic Figures Present		M0	Normal	Cytoplasm presence <= 25% Present	-16875	1667		0	1589			Diffuse Architecture Present		Both Clinical and Biochemical Assessments	Cortisol	2013-11-5	MALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	180	Invasion of Tumor Capsule Present	NO	Left		1				YES	YES		Mitotic Rate > 5/50 HPF Present	NO	Necrosis Absent						YES	Nuclear Grade III or IV Present	0	true	N0	T3	Stage III	TCGA-OR-A5LG.DA704AB1-8D08-48EC-9F62-A6B5E69E4DC7.pdf	20	20	5	40	0	0	95	95	WITH TUMOR	No imaging evidence of disease	YES	YES	Complete Remission/Response	No	NO	RX		Primary Tumor	01	Sinusoid Invasion Absent	YES			NO	NO	YES	OR	Adrenal	A	LIVING	6	Venous Invasion Absent	2008	0389b7f4-3b8e-48ab-8cbe-9b0523668dd2	TCGA-OR-A5LG-01A-11D-A29H-01	TCGA-OR-A5LG-01A-11D-A29I-10	0389b7f4-3b8e-48ab-8cbe-9b0523668dd2	TCGA-OR-A5LG-01A-11D-A29I-10	3C264BFC-0334-4FE8-8523-279090AF04AA	TCGA-OR-A5LG-01A-11D-A29I-10	TCGA-OR-A5LG-01A-11D-A29J-05	bdacf802-7670-445e-a1bc-1833c833940e	TCGA-OR-A5LG-01A-11D-A29I-10	TCGA-OR-A5LG-01	bdacf802-7670-445e-a1bc-1833c833940e	bdacf802-7670-445e-a1bc-1833c833940e	TCGA-OR-A5LG-01	bdacf802-7670-445e-a1bc-1833c833940e	TCGA-OR-A5LG-01A-11D-A29H-01	TCGA-OR-A5LG-01A-11R-A29W-13	TCGA-OR-A5LG-01A-11D-A29I-10
TCGA-OR-A5LH-01	1	TCGA-OR-A5LH-01	2385	1	TCGA-OR-A5LH	2385	0	2385	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			36	Atypical Mitotic Figures Present		M0	Normal	Cytoplasm presence <= 25% Absent	-13182	2731	2385	0				Diffuse Architecture Absent		Both Clinical and Biochemical Assessments	Androgen	2013-11-5	FEMALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	130	Invasion of Tumor Capsule Absent	NO	Left					5	YES	YES		Mitotic Rate > 5/50 HPF Absent	NO	Necrosis Present						NO	Nuclear Grade III or IV Absent		true	N0	T2	Stage II	TCGA-OR-A5LH.093D8D72-8D1B-4C23-A132-D0DCBB05DE26.pdf	20	20	0	40	0	5	95	95	WITH TUMOR	Persistent distant metastases	YES	NO	Progressive Disease	No	NO	R0		Primary Tumor	01	Sinusoid Invasion Present					NO	YES	OR	Adrenal	A	DECEASED	3	Venous Invasion Absent	2005	1944f75c-cb8f-4674-bdf9-bb6a8079dc29	TCGA-OR-A5LH-01A-11D-A29H-01	TCGA-OR-A5LH-01A-11D-A29I-10	1944f75c-cb8f-4674-bdf9-bb6a8079dc29	TCGA-OR-A5LH-01A-11D-A29I-10	6BB4B44E-2E16-41BA-8811-66740A96C3F3	TCGA-OR-A5LH-01A-11D-A29I-10	TCGA-OR-A5LH-01A-11D-A29J-05	44c5a1b9-e7e0-41ae-85e2-d1f05915ce3c	TCGA-OR-A5LH-01A-11D-A29I-10	TCGA-OR-A5LH-01	44c5a1b9-e7e0-41ae-85e2-d1f05915ce3c	44c5a1b9-e7e0-41ae-85e2-d1f05915ce3c	TCGA-OR-A5LH-01	44c5a1b9-e7e0-41ae-85e2-d1f05915ce3c	TCGA-OR-A5LH-01A-11D-A29H-01	TCGA-OR-A5LH-01A-11R-A29W-13	TCGA-OR-A5LH-01A-11D-A29I-10
TCGA-OR-A5LI-01	1	TCGA-OR-A5LI-01	436	1	TCGA-OR-A5LI	61	1	436	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer	YES	YES	42	Atypical Mitotic Figures Absent	TCGA-OR-A5LI-F61316	M1	Lung Involvement	Cytoplasm presence <= 25% Present	-15536	5353	436	0			61	Diffuse Architecture Present		Both Clinical and Biochemical Assessments	Androgen|Cortisol	2014-6-27	FEMALE	NO	Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	110	Invasion of Tumor Capsule Absent	NO	Right	NO		Imaging Suspected			NO	NO		Mitotic Rate > 5/50 HPF Present	NO	Necrosis Present	Imaging	Bone	Distant Metastasis		NO	YES	Nuclear Grade III or IV Present		true	N0	T4	Stage IV	TCGA-OR-A5LI.087A53B3-572F-4492-8D19-7CFE41C8DA39.pdf	0	0	0	0	0	5	95	98	WITH TUMOR	Persistent distant metastases	NO	NO	Progressive Disease	No	NO	R2		Primary Tumor	01	Sinusoid Invasion Present					NO	YES	OR	Adrenal	A	DECEASED	6	Venous Invasion Absent	1998	f2437da7-9419-483b-9357-1f1125b639c3	TCGA-OR-A5LI-01A-11D-A309-01	TCGA-OR-A5LI-01A-11D-A30A-10	f2437da7-9419-483b-9357-1f1125b639c3	TCGA-OR-A5LI-01A-11D-A30A-10		TCGA-OR-A5LI-01A-11D-A30A-10			TCGA-OR-A5LI-01A-11D-A30A-10						TCGA-OR-A5LI-01A-11D-A309-01		TCGA-OR-A5LI-01A-11D-A30A-10
TCGA-OR-A5LJ-01	1	TCGA-OR-A5LJ-01	1105	1	TCGA-OR-A5LJ			1105	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			54	Atypical Mitotic Figures Present		M1	Lung Involvement	Cytoplasm presence <= 25% Present	-20069	2633	1105	0				Diffuse Architecture Present	Lymph nodes	Both Clinical and Biochemical Assessments	Androgen|Cortisol	2013-11-7	FEMALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	110	Invasion of Tumor Capsule Absent	NO	Left			Imaging Suspected		10	YES	YES	YES	Mitotic Rate > 5/50 HPF Present	NO	Necrosis Present						YES	Nuclear Grade III or IV Present		true	N1	T2	Stage IV	TCGA-OR-A5LJ.B93073AF-A15A-4BAB-AC70-E16D89256DFC.pdf	0	0	0	0	0	5	95	98	WITH TUMOR	Persistent distant metastases	YES	YES	Progressive Disease	No	NO	R2		Primary Tumor	01	Sinusoid Invasion Present					NO	YES	OR	Adrenal	A	DECEASED	8	Venous Invasion Present	2005	0c9e9403-59c4-4c9a-aac2-17bc34947341	TCGA-OR-A5LJ-01A-11D-A29H-01	TCGA-OR-A5LJ-01A-11D-A29I-10	0c9e9403-59c4-4c9a-aac2-17bc34947341	TCGA-OR-A5LJ-01A-11D-A29I-10	E6673A36-9456-4788-8E0A-FED99D1849B9	TCGA-OR-A5LJ-01A-11D-A29I-10	TCGA-OR-A5LJ-01A-11D-A29J-05	744e863c-e24e-4eee-b0ee-ee24f2ef7401	TCGA-OR-A5LJ-01A-11D-A29I-10	TCGA-OR-A5LJ-01	744e863c-e24e-4eee-b0ee-ee24f2ef7401	744e863c-e24e-4eee-b0ee-ee24f2ef7401	TCGA-OR-A5LJ-01	744e863c-e24e-4eee-b0ee-ee24f2ef7401	TCGA-OR-A5LJ-01A-11D-A29H-01	TCGA-OR-A5LJ-01A-11R-A29W-13	TCGA-OR-A5LJ-01A-11D-A29I-10
TCGA-OR-A5LK-01	0	TCGA-OR-A5LK-01	2222	0	TCGA-OR-A5LK	2222	0	2222	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			62	Atypical Mitotic Figures Absent	TCGA-OR-A5LK-F59574	M0	Normal	Cytoplasm presence <= 25% Present	-22919	2096		0	2222			Diffuse Architecture Present			None	2014-5-15	MALE		Adrenocortical Carcinoma- Oncocytic Type	No	C74.0	8370/3	C74.0	YES	120	Invasion of Tumor Capsule Absent	NO	Right	NO				7	YES	YES		Mitotic Rate > 5/50 HPF Present	NO	Necrosis Present						NO	Nuclear Grade III or IV Present		true	N0	T2	Stage II	TCGA-OR-A5LK.4917D13C-6355-4E4B-8189-FE4443313F53.pdf	0	0	0	0	0	10	90	95	TUMOR FREE	No imaging evidence of disease	YES	NO	Complete Remission/Response	No	NO	R0		Primary Tumor	01	Sinusoid Invasion Absent	YES			NO	NO	YES	OR	Adrenal	A	LIVING	5	Venous Invasion Absent	2007	6c2af050-1558-41f9-b865-ebcfd83d44bf	TCGA-OR-A5LK-01A-11D-A29H-01	TCGA-OR-A5LK-01A-11D-A29I-10	6c2af050-1558-41f9-b865-ebcfd83d44bf	TCGA-OR-A5LK-01A-11D-A29I-10	4706C9EA-9C64-4CFA-A727-C371EE8CAAC8	TCGA-OR-A5LK-01A-11D-A29I-10	TCGA-OR-A5LK-01A-11D-A29J-05	6bce4f20-babf-4cbd-a962-6b977986e19d	TCGA-OR-A5LK-01A-11D-A29I-10	TCGA-OR-A5LK-01	6bce4f20-babf-4cbd-a962-6b977986e19d	6bce4f20-babf-4cbd-a962-6b977986e19d	TCGA-OR-A5LK-01	6bce4f20-babf-4cbd-a962-6b977986e19d	TCGA-OR-A5LK-01A-11D-A29H-01	TCGA-OR-A5LK-01A-11R-A29W-13	TCGA-OR-A5LK-01A-11D-A29I-10
TCGA-OR-A5LL-01	1	TCGA-OR-A5LL-01	1613	1	TCGA-OR-A5LL			1613	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			75	Atypical Mitotic Figures Present		M0	Normal	Cytoplasm presence <= 25% Present	-27607	1882	1613	0				Diffuse Architecture Present		Both Clinical and Biochemical Assessments	Androgen|Cortisol	2013-11-27	FEMALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	180	Invasion of Tumor Capsule Present	NO	Right		10			15	YES	YES	NO	Mitotic Rate > 5/50 HPF Present	NO	Necrosis Present						YES	Nuclear Grade III or IV Present	0	true	N0	T2	Stage II	TCGA-OR-A5LL.A898F0C7-9596-4DF1-9784-CAACFAB672D8.pdf	0	0	0	0	0	2	98	98	WITH TUMOR	No imaging evidence of disease	YES	YES	Complete Remission/Response	No	NO	R0		Primary Tumor	01	Sinusoid Invasion Absent	YES			YES	NO	YES	OR	Adrenal	A	DECEASED	7	Venous Invasion Absent	2007	fe311303-e123-4ebb-a729-3a52fa9e7b1e	TCGA-OR-A5LL-01A-11D-A29H-01	TCGA-OR-A5LL-01A-11D-A29I-10	fe311303-e123-4ebb-a729-3a52fa9e7b1e	TCGA-OR-A5LL-01A-11D-A29I-10	6E7DE852-5C21-4694-9B99-22FE8D927A7F	TCGA-OR-A5LL-01A-11D-A29I-10	TCGA-OR-A5LL-01A-11D-A29J-05	63f6ab7c-2ef7-42a3-afda-0289383a6976	TCGA-OR-A5LL-01A-11D-A29I-10	TCGA-OR-A5LL-01	63f6ab7c-2ef7-42a3-afda-0289383a6976	63f6ab7c-2ef7-42a3-afda-0289383a6976	TCGA-OR-A5LL-01	63f6ab7c-2ef7-42a3-afda-0289383a6976	TCGA-OR-A5LL-01A-11D-A29H-01	TCGA-OR-A5LL-01A-11R-A29W-13	TCGA-OR-A5LL-01A-11D-A29I-10
TCGA-OR-A5LM-01	0	TCGA-OR-A5LM-01	1858	0	TCGA-OR-A5LM	1858	0	1858	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			23	Atypical Mitotic Figures Present	TCGA-OR-A5LM-F59575	M0	Normal	Cytoplasm presence <= 25% Present	-8735	1821		0	1858			Diffuse Architecture Present		Both Clinical and Biochemical Assessments	Estrogen	2014-5-15	MALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	120	Invasion of Tumor Capsule Present	NO	Right	NO	32			18	YES	YES		Mitotic Rate > 5/50 HPF Present	NO	Necrosis Present						NO	Nuclear Grade III or IV Present	0	true	N0	T2	Stage II	TCGA-OR-A5LM.57A7E2E6-210B-41B1-8C22-9ED4930BCDEA.pdf	1	0	0	0	0	0	100	85	TUMOR FREE	No imaging evidence of disease	YES	YES	Complete Remission/Response	No	NO	R0		Primary Tumor	01	Sinusoid Invasion Absent	YES			NO	NO	YES	OR	Adrenal	A	LIVING	7	Venous Invasion Absent	2008	2152e9c3-9720-40b8-8652-533ddb5d26fc	TCGA-OR-A5LM-01A-11D-A29H-01		2152e9c3-9720-40b8-8652-533ddb5d26fc		8B5ED987-A6A4-4BEB-852A-E10F4CF37A30	TCGA-OR-A5LM-01A-11D-A29I-10	TCGA-OR-A5LM-01A-11D-A29J-05	3367029a-3e6f-49ef-8ff5-421aa0c71b4b		TCGA-OR-A5LM-01	3367029a-3e6f-49ef-8ff5-421aa0c71b4b	3367029a-3e6f-49ef-8ff5-421aa0c71b4b	TCGA-OR-A5LM-01	3367029a-3e6f-49ef-8ff5-421aa0c71b4b	TCGA-OR-A5LM-01A-11D-A29H-01	TCGA-OR-A5LM-01A-11R-A29W-13	
TCGA-OR-A5LN-01	0	TCGA-OR-A5LN-01	1916	0	TCGA-OR-A5LN	1916	0	1916	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			31	Atypical Mitotic Figures Present	TCGA-OR-A5LN-F59576	M0	Normal	Cytoplasm presence <= 25% Present	-11414	1790		0	1916			Diffuse Architecture Present			None	2014-5-15	FEMALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	120	Invasion of Tumor Capsule Present	NO	Right	NO	10			6	NO	NO		Mitotic Rate > 5/50 HPF Present	NO	Necrosis Absent						NO	Nuclear Grade III or IV Present	0	true	N0	T2	Stage II	TCGA-OR-A5LN.92EE5592-2CEC-4F7C-BF7B-A0A2CEE5E169.pdf	1	0	0	0	0	0	100	80	TUMOR FREE	No imaging evidence of disease	NO	YES	Complete Remission/Response	No	NO	R0		Primary Tumor	01	Sinusoid Invasion Absent					NO	YES	OR	Adrenal	A	LIVING	6	Venous Invasion Absent	2008	117463db-2904-42a4-a9c6-b8345a25be7d	TCGA-OR-A5LN-01A-11D-A29H-01	TCGA-OR-A5LN-01A-11D-A29I-10	117463db-2904-42a4-a9c6-b8345a25be7d	TCGA-OR-A5LN-01A-11D-A29I-10	AEE4D7BD-057F-4C4A-9544-2527784CBD29	TCGA-OR-A5LN-01A-11D-A29I-10	TCGA-OR-A5LN-01A-11D-A29J-05	8ab4c4ac-e348-4fa7-b15b-1b640d771fae	TCGA-OR-A5LN-01A-11D-A29I-10	TCGA-OR-A5LN-01	8ab4c4ac-e348-4fa7-b15b-1b640d771fae	8ab4c4ac-e348-4fa7-b15b-1b640d771fae	TCGA-OR-A5LN-01	8ab4c4ac-e348-4fa7-b15b-1b640d771fae	TCGA-OR-A5LN-01A-11D-A29H-01	TCGA-OR-A5LN-01A-11R-A29W-13	TCGA-OR-A5LN-01A-11D-A29I-10
TCGA-OR-A5LO-01	0	TCGA-OR-A5LO-01	2102	0	TCGA-OR-A5LO	153	1	2102	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer	YES	YES	61	Atypical Mitotic Figures Present	TCGA-OR-A5LO-F59577	M0	Normal	Cytoplasm presence <= 25% Present	-22370	1700		0	2102	1309	153	Diffuse Architecture Present		Both Clinical and Biochemical Assessments	Androgen|Estrogen	2014-5-15	FEMALE	YES	Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	170	Invasion of Tumor Capsule Present	NO	Right	NO	19			12	YES	YES		Mitotic Rate > 5/50 HPF Present	NO	Necrosis Present	Imaging	Lung	Distant Metastasis		YES	YES	Nuclear Grade III or IV Present	0	true	N0	T2	Stage II	TCGA-OR-A5LO.45C2478C-53EF-4422-A9EF-33C40A3AA275.pdf	0	0	0	0	0	0	100	95	WITH TUMOR	No imaging evidence of disease	YES	YES	Complete Remission/Response	No	NO	R0		Primary Tumor	01	Sinusoid Invasion Absent	YES			YES	NO	YES	OR	Adrenal	A	LIVING	7	Venous Invasion Absent	2008	c17224a7-066f-4b0c-b43d-0a0e346c555a	TCGA-OR-A5LO-01A-11D-A29H-01	TCGA-OR-A5LO-01A-11D-A29I-10	c17224a7-066f-4b0c-b43d-0a0e346c555a	TCGA-OR-A5LO-01A-11D-A29I-10	51B5F64E-06A8-48C6-AD83-B7006B707D55	TCGA-OR-A5LO-01A-11D-A29I-10	TCGA-OR-A5LO-01A-11D-A29J-05	a70e4d3e-993e-4ab7-95b9-1c52f452ef63	TCGA-OR-A5LO-01A-11D-A29I-10	TCGA-OR-A5LO-01	a70e4d3e-993e-4ab7-95b9-1c52f452ef63	a70e4d3e-993e-4ab7-95b9-1c52f452ef63	TCGA-OR-A5LO-01	a70e4d3e-993e-4ab7-95b9-1c52f452ef63	TCGA-OR-A5LO-01A-11D-A29H-01	TCGA-OR-A5LO-01A-11R-A29W-13	TCGA-OR-A5LO-01A-11D-A29I-10
TCGA-OR-A5LP-01	0	TCGA-OR-A5LP-01	1857	0	TCGA-OR-A5LP	1857	0	1857	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			37	Atypical Mitotic Figures Absent	TCGA-OR-A5LP-F59578	M0	Normal	Cytoplasm presence <= 25% Present	-13574	1396		0	1857			Diffuse Architecture Present			None	2014-5-15	FEMALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	120	Invasion of Tumor Capsule Present	NO	Right	NO	21			0	NO	NO		Mitotic Rate > 5/50 HPF Absent	NO	Necrosis Absent						NO	Nuclear Grade III or IV Present	0	true	N0	T2	Stage II	TCGA-OR-A5LP.FCD998EA-2EEA-4A94-80A6-D87F962BBC87.pdf	0	0	0	0	0	0	100	90	TUMOR FREE	No imaging evidence of disease	NO	YES	Complete Remission/Response	No	NO	R0		Primary Tumor	01	Sinusoid Invasion Present					NO	YES	OR	Adrenal	A	LIVING	5	Venous Invasion Absent	2009	ea969c54-cb09-464a-8841-3a4bf31ec61b	TCGA-OR-A5LP-01A-11D-A29H-01	TCGA-OR-A5LP-01A-11D-A29I-10	ea969c54-cb09-464a-8841-3a4bf31ec61b	TCGA-OR-A5LP-01A-11D-A29I-10	7D9FD532-600B-4BF1-987D-ADAA2895F9AB	TCGA-OR-A5LP-01A-11D-A29I-10	TCGA-OR-A5LP-01A-11D-A29J-05	62428588-d744-40ee-9318-f09c64e95898	TCGA-OR-A5LP-01A-11D-A29I-10	TCGA-OR-A5LP-01	62428588-d744-40ee-9318-f09c64e95898	62428588-d744-40ee-9318-f09c64e95898	TCGA-OR-A5LP-01	62428588-d744-40ee-9318-f09c64e95898	TCGA-OR-A5LP-01A-11D-A29H-01	TCGA-OR-A5LP-01A-11R-A29W-13	TCGA-OR-A5LP-01A-11D-A29I-10
TCGA-OR-A5LR-01	0	TCGA-OR-A5LR-01	853	0	TCGA-OR-A5LR	853	0	853	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			30	Atypical Mitotic Figures Present	TCGA-OR-A5LR-F59581	M0	Normal	Cytoplasm presence <= 25% Present	-11261	482		0	853			Diffuse Architecture Present		Both Clinical and Biochemical Assessments	Mineralocorticoids	2014-5-15	FEMALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	50	Invasion of Tumor Capsule Present	NO	Left	NO				6	YES	YES		Mitotic Rate > 5/50 HPF Present	NO	Necrosis Present						NO	Nuclear Grade III or IV Present		true	N0	T2	Stage II	TCGA-OR-A5LR.A1C555F3-4513-45C6-9A39-968902130B94.pdf	0	0	0	0	0	0	100	95	TUMOR FREE	No imaging evidence of disease	YES	NO	Complete Remission/Response	No	NO	R0		Primary Tumor	01	Sinusoid Invasion Absent	NO				NO	YES	OR	Adrenal	A	LIVING	7	Venous Invasion Absent	2011	ce60e213-0a8a-4cb4-8707-18b19096a74f	TCGA-OR-A5LR-01A-11D-A29H-01	TCGA-OR-A5LR-01A-11D-A29I-10	ce60e213-0a8a-4cb4-8707-18b19096a74f	TCGA-OR-A5LR-01A-11D-A29I-10		TCGA-OR-A5LR-01A-11D-A29I-10	TCGA-OR-A5LR-01A-11D-A29J-05	70b87c96-d585-4260-aa9a-7a5ee37d1b10	TCGA-OR-A5LR-01A-11D-A29I-10	TCGA-OR-A5LR-01	70b87c96-d585-4260-aa9a-7a5ee37d1b10	70b87c96-d585-4260-aa9a-7a5ee37d1b10	TCGA-OR-A5LR-01	70b87c96-d585-4260-aa9a-7a5ee37d1b10	TCGA-OR-A5LR-01A-11D-A29H-01	TCGA-OR-A5LR-01A-11R-A29W-13	TCGA-OR-A5LR-01A-11D-A29I-10
TCGA-OR-A5LS-01	0	TCGA-OR-A5LS-01	1096	0	TCGA-OR-A5LS	1096	0	1096	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			34	Atypical Mitotic Figures Absent	TCGA-OR-A5LS-F59579	M0	Normal	Cytoplasm presence <= 25% Present	-12663	725		0	1096			Diffuse Architecture Absent		Both Clinical and Biochemical Assessments	Androgen|Cortisol	2014-5-15	FEMALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	100	Invasion of Tumor Capsule Absent	NO	Right	NO				7	YES	YES		Mitotic Rate > 5/50 HPF Present	NO	Necrosis Present						NO	Nuclear Grade III or IV Present		true	N0	T2	Stage II	TCGA-OR-A5LS.31004530-E017-4913-A8AA-7AE709EAE0F1.pdf	0	0	0	0	0	0	100	95	TUMOR FREE	No imaging evidence of disease	YES	NO	Complete Remission/Response	No	NO	R0		Primary Tumor	01	Sinusoid Invasion Present	YES			NO	NO	YES	OR	Adrenal	A	LIVING	6	Venous Invasion Present	2011	ff8cf96c-3447-4e79-bbc0-44a019bbf3ce	TCGA-OR-A5LS-01A-11D-A29H-01	TCGA-OR-A5LS-01A-11D-A29I-10	ff8cf96c-3447-4e79-bbc0-44a019bbf3ce	TCGA-OR-A5LS-01A-11D-A29I-10	9F4DFEE6-3193-44C2-98BE-6649DB11A67C	TCGA-OR-A5LS-01A-11D-A29I-10	TCGA-OR-A5LS-01A-11D-A29J-05	67a0828e-86c3-4c46-b05c-104000425669	TCGA-OR-A5LS-01A-11D-A29I-10	TCGA-OR-A5LS-01	67a0828e-86c3-4c46-b05c-104000425669	67a0828e-86c3-4c46-b05c-104000425669	TCGA-OR-A5LS-01	67a0828e-86c3-4c46-b05c-104000425669	TCGA-OR-A5LS-01A-11D-A29H-01	TCGA-OR-A5LS-01A-11R-A29W-13	TCGA-OR-A5LS-01A-11D-A29I-10
TCGA-OR-A5LT-01	0	TCGA-OR-A5LT-01	549	0	TCGA-OR-A5LT	549	0	549	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			57	Atypical Mitotic Figures Present	TCGA-OR-A5LT-F59582	M0	Normal	Cytoplasm presence <= 25% Present	-21032	178		0	549			Diffuse Architecture Present			None	2014-5-15	MALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	160	Invasion of Tumor Capsule Present	NO	Left	NO	18			10	YES	YES		Mitotic Rate > 5/50 HPF Present	NO	Necrosis Present						NO	Nuclear Grade III or IV Present	0	true	N0	T3	Stage III	TCGA-OR-A5LT.6C9B7DE2-682F-4F4A-8879-159F9989C40C.pdf	0	0	0	0	0	0	100	95	TUMOR FREE	No imaging evidence of disease	YES	YES	Complete Remission/Response	No	NO	R0		Primary Tumor	01	Sinusoid Invasion Absent	YES			NO	NO	YES	OR	Adrenal	A	LIVING	8	Venous Invasion Present	2012	55359604-76a7-43a3-b621-09ca64d547d2	TCGA-OR-A5LT-01A-11D-A29H-01	TCGA-OR-A5LT-01A-11D-A29I-10	55359604-76a7-43a3-b621-09ca64d547d2	TCGA-OR-A5LT-01A-11D-A29I-10	88870133-85F4-49A2-92D1-12E92055C7E7	TCGA-OR-A5LT-01A-11D-A29I-10	TCGA-OR-A5LT-01A-11D-A29J-05	c18bba08-b10a-4237-96a6-5f89efa59826	TCGA-OR-A5LT-01A-11D-A29I-10	TCGA-OR-A5LT-01	c18bba08-b10a-4237-96a6-5f89efa59826	c18bba08-b10a-4237-96a6-5f89efa59826	TCGA-OR-A5LT-01	c18bba08-b10a-4237-96a6-5f89efa59826	TCGA-OR-A5LT-01A-11D-A29H-01	TCGA-OR-A5LT-01A-11R-A29W-13	TCGA-OR-A5LT-01A-11D-A29I-10
TCGA-OU-A5PI-01	0	TCGA-OU-A5PI-01	1171	0	TCGA-OU-A5PI	351	1	1171	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer	YES	YES	53	Atypical Mitotic Figures Absent	TCGA-OU-A5PI-F65711	M1	Lung Involvement	Cytoplasm presence <= 25% Absent	-19492	577		0	1171	384	351	Diffuse Architecture Absent			None	2014-9-29	FEMALE	NO	Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	160	Invasion of Tumor Capsule Present	NO	Left	NO	3	Other, specify	Resection		YES	YES	NO	Mitotic Rate > 5/50 HPF Absent	YES	Necrosis Present	Imaging	Lung	Distant Metastasis		YES	YES	Nuclear Grade III or IV Absent	3	false	N1	T2	Stage IV	TCGA-OU-A5PI.2AA8FA9B-A202-48AB-A543-6E0B1B45B1D4.pdf	0	0	10	0	0	10	80	95	WITH TUMOR	Persistent distant metastases	YES	YES	Stable Disease	No	NO		RET Negative	Primary Tumor	01	Sinusoid Invasion Absent					NO	YES	OU	Adrenal	A	LIVING	2	Venous Invasion Absent	2011	d42d916b-0232-44e0-8fb8-97d3da177be7	TCGA-OU-A5PI-01A-12D-A29H-01	TCGA-OU-A5PI-01A-12D-A29I-10	d42d916b-0232-44e0-8fb8-97d3da177be7	TCGA-OU-A5PI-01A-12D-A29I-10	A6D0B6AB-D7DE-4233-805C-E85505D0BE77	TCGA-OU-A5PI-01A-12D-A29I-10	TCGA-OU-A5PI-01A-12D-A29J-05	7d3369ab-b556-45c5-aaaf-e7cd9ac0d454	TCGA-OU-A5PI-01A-12D-A29I-10	TCGA-OU-A5PI-01	7d3369ab-b556-45c5-aaaf-e7cd9ac0d454	7d3369ab-b556-45c5-aaaf-e7cd9ac0d454	TCGA-OU-A5PI-01	7d3369ab-b556-45c5-aaaf-e7cd9ac0d454	TCGA-OU-A5PI-01A-12D-A29H-01	TCGA-OU-A5PI-01A-12R-A29W-13	TCGA-OU-A5PI-01A-12D-A29I-10
TCGA-P6-A5OF-01	1	TCGA-P6-A5OF-01	207	1	TCGA-P6-A5OF			207	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			55			M0	Vena Cava Involvement/thrombus		-20106		207	0						Both Clinical and Biochemical Assessments	Androgen|Cortisol	2013-8-15	FEMALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES				Right						NO			Mitotic Rate > 5/50 HPF Present	NO	Necrosis Present						YES	Nuclear Grade III or IV Present			N0	T4	Stage III										WITH TUMOR	Persistent distant metastases	NO	NO		No	NO	RX		Primary Tumor	01						NO	YES	P6	Adrenal		DECEASED	4	Venous Invasion Present	2010			TCGA-P6-A5OF-01A-11D-A29I-10		TCGA-P6-A5OF-01A-11D-A29I-10		TCGA-P6-A5OF-01A-11D-A29I-10	TCGA-P6-A5OF-01A-11D-A29J-05	ca5f547a-8ec9-4436-9878-1f1cab2fa329	TCGA-P6-A5OF-01A-11D-A29I-10		ca5f547a-8ec9-4436-9878-1f1cab2fa329	ca5f547a-8ec9-4436-9878-1f1cab2fa329	TCGA-P6-A5OF-01	ca5f547a-8ec9-4436-9878-1f1cab2fa329		TCGA-P6-A5OF-01A-11R-A29W-13	TCGA-P6-A5OF-01A-11D-A29I-10
TCGA-P6-A5OG-01	1	TCGA-P6-A5OG-01	383	1	TCGA-P6-A5OG			383	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			45	Atypical Mitotic Figures Absent		M1	Lung Involvement	Cytoplasm presence <= 25% Present	-16659	426	383	0				Diffuse Architecture Absent		Biochemical Assessment	Cortisol	2013-8-15	FEMALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	200	Invasion of Tumor Capsule Present	NO	Left		6	Biopsy Proven			NO			Mitotic Rate > 5/50 HPF Absent	NO	Necrosis Present						YES	Nuclear Grade III or IV Present	0	false	N0	T4	Stage IV	TCGA-P6-A5OG.4F591001-D8B2-4B68-A219-45EBA6903A80.pdf	0	0	0	8	0	5	95	90	WITH TUMOR	Persistent distant metastases	NO	YES	Complete Remission/Response	Yes	NO	R2		Primary Tumor	01	Sinusoid Invasion Absent					NO	YES	P6	Adrenal	A	DECEASED	4	Venous Invasion Absent	2011	2a6bd14e-359d-4edb-b404-d0f85d6a0e1c	TCGA-P6-A5OG-01A-22D-A29H-01	TCGA-P6-A5OG-01A-22D-A29I-10	2a6bd14e-359d-4edb-b404-d0f85d6a0e1c	TCGA-P6-A5OG-01A-22D-A29I-10	18B5333E-0649-4BBB-9271-5779C2D13BC8	TCGA-P6-A5OG-01A-22D-A29I-10	TCGA-P6-A5OG-01A-22D-A29J-05	b5a3bdce-d4ad-43a6-8fbc-1e9d31dc2564	TCGA-P6-A5OG-01A-22D-A29I-10	TCGA-P6-A5OG-01	b5a3bdce-d4ad-43a6-8fbc-1e9d31dc2564	b5a3bdce-d4ad-43a6-8fbc-1e9d31dc2564	TCGA-P6-A5OG-01	b5a3bdce-d4ad-43a6-8fbc-1e9d31dc2564	TCGA-P6-A5OG-01A-22D-A29H-01	TCGA-P6-A5OG-01A-22R-A29W-13	TCGA-P6-A5OG-01A-22D-A29I-10
TCGA-P6-A5OH-01	1	TCGA-P6-A5OH-01	0	1	TCGA-P6-A5OH	0	0	0	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			59			M1		Cytoplasm presence <= 25% Present	-21627	1021	0	0				Diffuse Architecture Present				2014-3-25	FEMALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	200		NO	Right			Biopsy Proven			NO				NO	Necrosis Present						NO	Nuclear Grade III or IV Present		false	N0	T4	Stage IV	TCGA-P6-A5OH.349F5609-E653-4CF0-B63C-AF01D68D40E7.pdf	0	0	0	0	0	20	80	90	WITH TUMOR		NO			No	NO	R2		Primary Tumor	01						NO	YES	P6	Adrenal	A	DECEASED	4		2010	3c8a901a-645d-401d-938b-abc7d6e2ad2a	TCGA-P6-A5OH-01A-11D-A309-01	TCGA-P6-A5OH-01A-11D-A30A-10	3c8a901a-645d-401d-938b-abc7d6e2ad2a	TCGA-P6-A5OH-01A-11D-A30A-10		TCGA-P6-A5OH-01A-11D-A30A-10			TCGA-P6-A5OH-01A-11D-A30A-10						TCGA-P6-A5OH-01A-11D-A309-01		TCGA-P6-A5OH-01A-11D-A30A-10
TCGA-PA-A5YG-01	0	TCGA-PA-A5YG-01	756	0	TCGA-PA-A5YG	756	0	756	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			51		TCGA-PA-A5YG-F69304	M0	Normal		-18926	85		0	756							2014-12-31	MALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	440		NO	Left	NO					NO	NO			NO							NO			true	N0	T2	Stage II	TCGA-PA-A5YG.9C523464-BFDB-4C7A-972E-2EBECDBBFF3E.pdf	0	0	0	0	0	10	90	90	TUMOR FREE	No imaging evidence of disease	NO	NO	Complete Remission/Response	No	NO	R0		Primary Tumor	01						YES	NO	PA	Adrenal	A	LIVING			2012	0aac83d9-dfb0-4aa8-9fc4-b12acef7fdee	TCGA-PA-A5YG-01A-11D-A29H-01	TCGA-PA-A5YG-01A-11D-A29I-10	0aac83d9-dfb0-4aa8-9fc4-b12acef7fdee	TCGA-PA-A5YG-01A-11D-A29I-10	78AB014F-E03C-4109-9348-34862B626270	TCGA-PA-A5YG-01A-11D-A29I-10	TCGA-PA-A5YG-01A-11D-A29J-05	379e288c-fa30-460c-bb57-d3b6f09b1483	TCGA-PA-A5YG-01A-11D-A29I-10	TCGA-PA-A5YG-01	379e288c-fa30-460c-bb57-d3b6f09b1483	379e288c-fa30-460c-bb57-d3b6f09b1483	TCGA-PA-A5YG-01	379e288c-fa30-460c-bb57-d3b6f09b1483	TCGA-PA-A5YG-01A-11D-A29H-01	TCGA-PA-A5YG-01A-11R-A29W-13	TCGA-PA-A5YG-01A-11D-A29I-10
TCGA-PK-A5H8-01	0	TCGA-PK-A5H8-01	3240	0	TCGA-PK-A5H8	3240	0	3240	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			42						-15373	3025		0	3240							2013-9-16	MALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	210		NO	Right																	NO			false				TCGA-PK-A5H8.706EC715-C6CD-49A9-8993-D6E5B20AED95.pdf	1	0	0	0	0	0	100	80	TUMOR FREE		NO	NO		No	NO			Primary Tumor	01						NO	YES	PK	Adrenal	A	LIVING			2004			TCGA-PK-A5H8-01A-11D-A29I-10		TCGA-PK-A5H8-01A-11D-A29I-10	E8C935A8-A842-414D-9E8A-AF40D7BE64A9	TCGA-PK-A5H8-01A-11D-A29I-10	TCGA-PK-A5H8-01A-11D-A29J-05	cdb932bf-d02c-4c3c-9e71-22eb12623977	TCGA-PK-A5H8-01A-11D-A29I-10		cdb932bf-d02c-4c3c-9e71-22eb12623977	cdb932bf-d02c-4c3c-9e71-22eb12623977	TCGA-PK-A5H8-01	cdb932bf-d02c-4c3c-9e71-22eb12623977		TCGA-PK-A5H8-01A-11R-A29W-13	TCGA-PK-A5H8-01A-11D-A29I-10
TCGA-PK-A5H9-01	0	TCGA-PK-A5H9-01	616	0	TCGA-PK-A5H9	616	0	616	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			27	Atypical Mitotic Figures Present	TCGA-PK-A5H9-F62621	M0		Cytoplasm presence <= 25% Present	-10173	92		0	616			Diffuse Architecture Present		Both Clinical and Biochemical Assessments	Androgen	2014-8-11	FEMALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	90	Invasion of Tumor Capsule Absent	NO	Right	NO				2	NO	NO		Mitotic Rate > 5/50 HPF Absent	YES	Necrosis Absent						NO	Nuclear Grade III or IV Absent		false	N0	T2	Stage II	TCGA-PK-A5H9.A323FD5A-1C3E-49D3-A7EA-04E3663D6883.pdf	1	0	0	0	0	0	100	80	TUMOR FREE	No imaging evidence of disease	NO	NO	Complete Remission/Response	No	NO	R0		Primary Tumor	01	Sinusoid Invasion Absent					NO	YES	PK	Adrenal	A	LIVING	4	Venous Invasion Present	2012	864512c9-938e-42ad-aad5-fbddb2bfae1a	TCGA-PK-A5H9-01A-11D-A29H-01	TCGA-PK-A5H9-01A-11D-A29I-10	864512c9-938e-42ad-aad5-fbddb2bfae1a	TCGA-PK-A5H9-01A-11D-A29I-10	52E291F2-445C-4088-88AD-04034A488599	TCGA-PK-A5H9-01A-11D-A29I-10	TCGA-PK-A5H9-01A-11D-A29J-05	207683b6-6a60-44ef-8eb2-d26ed9a7de76	TCGA-PK-A5H9-01A-11D-A29I-10	TCGA-PK-A5H9-01	207683b6-6a60-44ef-8eb2-d26ed9a7de76	207683b6-6a60-44ef-8eb2-d26ed9a7de76	TCGA-PK-A5H9-01	207683b6-6a60-44ef-8eb2-d26ed9a7de76	TCGA-PK-A5H9-01A-11D-A29H-01	TCGA-PK-A5H9-01A-11R-A29W-13	TCGA-PK-A5H9-01A-11D-A29I-10
TCGA-PK-A5HA-01	0	TCGA-PK-A5HA-01	1201	0	TCGA-PK-A5HA	1201	0	1201	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			63	Atypical Mitotic Figures Present	TCGA-PK-A5HA-F62620	M0		Cytoplasm presence <= 25% Present	-23345	701		0	1201			Diffuse Architecture Present			None	2014-8-11	MALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	130	Invasion of Tumor Capsule Present	NO	Left	NO	1				NO	NO		Mitotic Rate > 5/50 HPF Present		Necrosis Present						NO	Nuclear Grade III or IV Present	0	false	N0	T1	Stage I	TCGA-PK-A5HA.B98EC873-CB6D-4395-A473-C46EC4D2DB00.pdf	2	0	0	0	5	0	95	80	TUMOR FREE	No imaging evidence of disease	NO	YES	Complete Remission/Response	No	NO	R0		Primary Tumor	01	Sinusoid Invasion Present					NO	YES	PK	Adrenal	A	LIVING	8	Venous Invasion Absent	2011	33d5ecfd-6c11-4e35-98e0-4bf334bc3d09	TCGA-PK-A5HA-01A-11D-A29H-01	TCGA-PK-A5HA-01A-11D-A29I-10	33d5ecfd-6c11-4e35-98e0-4bf334bc3d09	TCGA-PK-A5HA-01A-11D-A29I-10	85DDE23B-20FB-450B-9D82-609D7F4C6207	TCGA-PK-A5HA-01A-11D-A29I-10	TCGA-PK-A5HA-01A-11D-A29J-05	69d7a879-cf23-44d0-8a44-050b7a3f4b03	TCGA-PK-A5HA-01A-11D-A29I-10	TCGA-PK-A5HA-01	69d7a879-cf23-44d0-8a44-050b7a3f4b03	69d7a879-cf23-44d0-8a44-050b7a3f4b03	TCGA-PK-A5HA-01	69d7a879-cf23-44d0-8a44-050b7a3f4b03	TCGA-PK-A5HA-01A-11D-A29H-01	TCGA-PK-A5HA-01A-11R-A29W-13	TCGA-PK-A5HA-01A-11D-A29I-10
TCGA-PK-A5HB-01	0	TCGA-PK-A5HB-01	1293	0	TCGA-PK-A5HB			1293	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			63						-23293	3385		0	1293							2013-9-16	MALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	70		NO	Left		2				NO											YES			false				TCGA-PK-A5HB.5C732114-DD55-41D6-84C1-9BEDB7DF4345.pdf	1	0	0	0	0	0	100	80	WITH TUMOR		YES	YES		Yes	YES			Primary Tumor	01						NO	YES	PK	Adrenal	A	LIVING			2003	211b34f8-8871-4111-aa1f-a7f838409fa3	TCGA-PK-A5HB-01A-11D-A29H-01	TCGA-PK-A5HB-01A-11D-A29I-10	211b34f8-8871-4111-aa1f-a7f838409fa3	TCGA-PK-A5HB-01A-11D-A29I-10		TCGA-PK-A5HB-01A-11D-A29I-10	TCGA-PK-A5HB-01A-11D-A29J-05	c92f7cf7-f63b-4f04-a391-193f65a6f8a7	TCGA-PK-A5HB-01A-11D-A29I-10	TCGA-PK-A5HB-01	c92f7cf7-f63b-4f04-a391-193f65a6f8a7	c92f7cf7-f63b-4f04-a391-193f65a6f8a7	TCGA-PK-A5HB-01	c92f7cf7-f63b-4f04-a391-193f65a6f8a7	TCGA-PK-A5HB-01A-11D-A29H-01	TCGA-PK-A5HB-01A-11R-A29W-13	TCGA-PK-A5HB-01A-11D-A29I-10
TCGA-PK-A5HC-01	0	TCGA-PK-A5HC-01	679	0	TCGA-PK-A5HC			679	Adrenal gland	TCGA Adrenocortical Cancer	adrenocortical cancer			44			M0	Vena Cava Involvement/thrombus	Cytoplasm presence <= 25% Present	-16182	359		0	679			Diffuse Architecture Present		Both Clinical and Biochemical Assessments	Androgen|Cortisol	2014-3-13	FEMALE		Adrenocortical carcinoma- Usual Type	No	C74.0	8370/3	C74.0	YES	120	Invasion of Tumor Capsule Present	NO	Right		3			19	YES	NO		Mitotic Rate > 5/50 HPF Present		Necrosis Present						YES	Nuclear Grade III or IV Present	0	false	N0	T4	Stage III	TCGA-PK-A5HC.760C639D-B101-441C-8081-30908D56EDA2.pdf	1	0	0	0	0	0	100	80	WITH TUMOR	No imaging evidence of disease	NO	YES	Complete Remission/Response	No	NO	R1		Primary Tumor	01	Sinusoid Invasion Present		YES	YES		NO	YES	PK	Adrenal	A	LIVING	9	Venous Invasion Present	2011	c00b53a9-bb48-4841-974d-7087eacd5420	TCGA-PK-A5HC-01A-11D-A309-01	TCGA-PK-A5HC-01A-11D-A30A-10	c00b53a9-bb48-4841-974d-7087eacd5420	TCGA-PK-A5HC-01A-11D-A30A-10		TCGA-PK-A5HC-01A-11D-A30A-10			TCGA-PK-A5HC-01A-11D-A30A-10						TCGA-PK-A5HC-01A-11D-A309-01		TCGA-PK-A5HC-01A-11D-A30A-10
